Resultados de concursos anteriores - Fundação "la Caixa"

Resultados CaixaResearch Health call 2025

CaixaResearch Health call 2025 information
Orçamento total	26.602.911,25 €
Número de candidaturas apresentadas	714
Número de candidaturas avaliadas	638
Número de candidaturas pré-selecionadas	91
Número de projetos selecionados	34
Taxa de sucesso	4,8 %

Quadro 1. Informações gerais sobre o Concurso CaixaResearch de Investigação em Saúde 2025

Figure 1: Budget distribution by territory

Figura 1. Distribuição do orçamento pelos vários territórios

ÁREA TEMÁTICA	CANDIDATURAS APRESENTADAS	CANDIDATURAS ELEGÍVEIS		CANDIDATURAS PRÉ-SELECIONADAS		PROJETOS SELECIONADOS
Doenças cardiovasculares e doenças metabólicas	107	92	86,0 %	18	16,8 %	7	6,5 %
Neurociências	187	169	90,4 %	19	10,2 %	8	4,3 %
Doenças infeciosas	103	93	90,3 %	18	17,5 %	6	5,6 %
Oncologia	166	148	89,2 %	18	10,8 %	7	4,2 %
Tecnologias facilitadoras	151	136	90,1 %	18	11,9 %	6	4,0 %
Total	714	638	89,4 %	91	12,7 %	34	4,8 %

Quadro 2. Percentagem de candidaturas pré-selecionadas e projetos selecionados, relativamente ao número de candidaturas apresentadas em cada área temática

LÍDER DO PROJETO	CANDIDATURAS APRESENTADAS	CANDIDATURAS ELEGÍVEIS	CANDIDATURAS PRÉ-SELECIONADAS	PROJETOS SELECIONADOS	TAXA DE SUCESSO
Mulheres	316	278	33	8	2,5 %
Homens	395	358	58	26	6,6 %
Outros	1	1	0	0	0,0 %
Prefere não dizer	2	1	0	0	0,0 %

Quadro 3. Resultados por sexo

Resultados CaixaResearch Health call 2024

CaixaResearch Health call 2024 information
Orçamento total	25.568.081,32 €
Número de candidaturas apresentadas	580
Número de candidaturas avaliadas	535
Número de candidaturas pré-selecionadas	90
Número de projetos selecionados	29
Taxa de sucesso	5,0 %

Quadro 1. Informações gerais sobre o Concurso CaixaResearch de Investigação em Saúde 2024

Figure 1: Budget distribution by territory

Figura 1. Distribuição do orçamento pelos vários territórios

ÁREA TEMÁTICA	CANDIDATURAS APRESENTADAS	CANDIDATURAS ELEGÍVEIS		CANDIDATURAS PRÉ-SELECIONADAS		PROJETOS SELECIONADOS
Doenças cardiovasculares e doenças metabólicas	82	76	92,7 %	18	22,0 %	5	6,1 %
Neurociências	156	145	92,9 %	18	11,5 %	5	3,2 %
Doenças infeciosas	87	78	89,7 %	18	20,7 %	7	8,0 %
Oncologia	130	120	92,3 %	18	13,8 %	6	4,6 %
Tecnologias facilitadoras	125	116	92,8 %	18	14,4 %	6	4,8 %
Total	580	535	92,2 %	90	15,5 %	29	5,0 %

Quadro 2. Percentagem de candidaturas pré-selecionadas e projetos selecionados, relativamente ao número de candidaturas apresentadas em cada área temática

LÍDER DO PROJETO	CANDIDATURAS APRESENTADAS	CANDIDATURAS ELEGÍVEIS	CANDIDATURAS PRÉ-SELECIONADAS	PROJETOS SELECIONADOS	TAXA DE SUCESSO
Mulheres	236	220	34	11	4,7 %
Homens	338	309	55	17	5,0 %
Outros	3	3	0	0	0,0 %
Prefere não dizer	3	3	1	1	33,3 %

Quadro 3. Resultados por sexo

Resultados CaixaResearch Health call 2023

CaixaResearch Health call 2023 information
Total Budget	25.334.874,34 €
Number of proposals submitted	493
Number of eligible proposals*	430
Number of projects preselected	85
Number of projects selected	33
Success rate	6,7 %

* All the proposals submitted passed the format eligibility phase, thus the eligible proposals are those that also passed the content eligibility phase.

Table 1. General information of CaixaResearch Health Call 2023

Figure 1: Budget distribution by territory

Figure 1. Budget distribution by territory

Thematic Area	Proposals submitted	Eligible proposals	Proj. Preselected (peer review)	Proj. Selected (expert panel)
Cardiovascular and metabolic diseases	68	53	17	7
Neurosciences	122	111	17	7
Infectious diseases	69	59	17	8
Oncology	110	96	17	6
Enabling technologies	124	111	17	5

Table 2. Results by thematic area and evaluation phase

Thematic area		Proposals submitted	Eligible proposals	Proj. Preselected	Proj. Selected
Cardiovascular and metabolic diseases	Individual	18	11	6	3
Cardiovascular and metabolic diseases	Research consortium	50	42	11	4
Neurosciences	Individual	45	38	5	1
Neurosciences	Research consortium	77	73	12	6
Infectious diseases	Individual	33	28	8	7
Infectious diseases	Research consortium	36	31	9	1
Oncology	Individual	50	42	5	2
Oncology	Research consortium	60	54	12	4
Enabling technologies	Individual	28	21	0	0
Enabling technologies	Research consortium	96	90	17	5

Table 3. Number of Individual and Research Consortium projects compared to the total number of projects of each thematic area

Project leader	Proposals submitted	Eligible proposals	Proj. Preselected	Proj. Selected	Success rate
Women	196	176	31	13	6,6 %
Men	292	249	53	20	6,8 %
Others / Prefer not to say	5	5	1	0	0,0 %

Table 4. Results by gender

Resultados CaixaResearch Health call 2022

CaixaResearch Health call 2022 information
Total Budget	23.148.611,88 €
Number of projects presented	547
Number of projects evaluated	546
Number of projects preselected	80
Number of projects selected	33
Success rate	6,04 %

Table 1: General information of CaixaResearch Health Call 2022.

Figure 1: Budget distribution by territory

Figure 1: Budget distribution by territory

Thematic Area	Proj. Evaluated	Proj. Preselected (peer review)		Proj. Selected (expert panel)
Cardiovascular and metabolic diseases	63	16	25,4 %	5	7,9 %
Neuroscience	163	16	9,8 %	8	4,9 %
Infectious diseases	72	16	22,2 %	8	11,1 %
Oncology	111	16	14,4 %	6	5,4 %
Enabling technologies	137	16	11,7 %	6	4,4 %
	546	80	14,7 %	33	6,0 %

Table 2: % of the preselected and selected projects compared to the submitted projects in each thematic area.

Thematic area		Proj. Evaluated	Proj. Preselected	Proj. Selected
Cardiovascular and metabolic diseases	Individual	22	5	1
	Research Consortium	41	11	4
	Total	63	16	5
Neuroscience	Individual	70	5	4
	Research Consortium	93	11	4
	Total	163	16	8
Infectious disease	Individual	33	7	7
	Research Consortium	39	9	1
	Total	72	16	8
Oncology	Individual	52	5	3
	Research Consortium	59	11	3
	Total	111	16	6
Enabling technologies	Individual	34	1	1
	Research Consortium	103	15	5
	Total	137	16	6
		549	80	33

Table 3: Number of Individual and Research Consortium projects compared to the total number of projects of each thematic area.

Resultados CaixaResearch Health call 2021

CaixaResearch Health call 2021 information
HR21 Budget	22.115.490,50 €
Number of projects presented	644
Number of projects evaluated	644
Number of projects preselected	70
Number of projects selected	30
Success rate	4,66 %

Table: General information of Health Research 2021 Call for Proposals.

Resultados CaixaResearch Health call 2020

CaixaResearch Health call 2020 information
HR20 Budget	15.200.128 €
Number of projects presented	602
Number of projects evaluated	600
Number of projects preselected	62
Number of projects selected	21
Success rate	3,50 %

Table: General information of Health Research 2020 Call for Proposals.

Resultados CaixaResearch Health call 2019

CaixaResearch Health call 2019 information
HR18 Budget	15.376.337 €
Number of projects presented	632
Number of projects evaluated	629
Number of projects preselected	75
Number of projects selected	22
Success rate	3,50 %

Table: General information of Health Research 2019 Call for Proposals.

Resultados CaixaResearch Health call 2018

CaixaResearch Health call 2018 information
HR17 Budget	12.000.000 €
Number of projects presented	785
Number of projects evaluated	785
Number of projects preselected	77
Number of projects selected	20

Table: General information of Health Research 2018 Call for Proposals.

Projetos selecionados CaixaResearch Health call 2025

CODE	PROJECT TITLE	PROJECT LEADER	HOST ORGANIZATION	PARTNER ORGANIZATIONS	THEMATIC AREA	CATEGORY	BUDGET (€)
HR25-00055	Advanced platform for targeting tumor-associated glycans	June Ereño	Asociación Centro de Investigación Cooperativa en Biociencias-CIC bioGUNE	Universidad del Pais Vasco (UPV/EHU); Asociación Instituto de Investigación Sanitaria Biogipuzkoa; Universitat Rovira i Virgili; Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud	Enabling Technologies	HR Consortium	998.670,00
HR25-00092	Safety, pharmacokynetics and short-term effects of oral CBD in hypoxic-ischemic newborns	José Martínez	Fundación para la Investigación Biomédica del Hospital Clínico San Carlos	N/A	Neuroscience	HR Single Organization	488.070,00
HR25-00177	Deciphering the contribution of common non-coding genetic variation to Autism Spectrum Disorders	Diogo Castro	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação	Institute of Science and Technology Austria (ISTA); The University of Auckland	Neuroscience	HR Consortium	731.631,00
HR25-00225	Liquid-walled circuits for anticoagulant-free Extra-corporeal Membrane Oxygenation	Thomas Hermans	FUNDACIÓN IMDEA NANOCIENCIA	Fundación para la Investigación Biomédica del Hospital Gregorio Marañón	Enabling Technologies	HR Consortium	999.816,40
HR25-00235	Going Beyond Traditional Therapies to Tailor TGF-β and SMAD Regulation in Pediatric Rare Diseases.	Maria J. Macias	Fundació Institut de Recerca Biomèdica (IRB Barcelona)	Universidad de Santiago de Compostela; Asociación Síndrome de Myhre España	Cardiovascular and associated metabolic diseases	HR Consortium	771.800,00
HR25-00241	High-resolution profiling of HIV-1 reservoir and immune response for revealing HIV cure	Ezequiel Ruiz-Mateos	Fundación para la Gestión de la Investigación en Salud de Sevilla	Fundació Institut d'Investigació Sanitària Pere Virgili; Fundació Privada Institut de Recerca Sobre Immunopatologies-Caixa IRSICAIXA; Harvard University; Projecte dels Noms-Hispanosida; Adhara Asociación VIH/Sida	Infectious disease	HR Consortium	999.952,40
HR25-00303	Assembly rules of plasmid communities in bacteria: towards predicting antimicrobial resistance	Alvaro San Millan	Agencia Estatal Consejo Superior de Investigaciones Científicas, M.P.	Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal	Infectious disease	HR Consortium	989.250,00
HR25-00331	Transcriptional and epigenetic regulation of an anti-diabetogenic immunoregulatory cell pathway	Pere Santamaria	Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer	N/A	Cardiovascular and associated metabolic diseases	HR Single Organization	500.000,00
HR25-00392	Loco-radiolysed treatment for glioblastoma self-enhanced chemotherapy and targeted RNA delivery	Bruno Sarmento	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação	Universidade do Minho; University of Nottingham	Enabling Technologies	HR Consortium	989.290,00
HR25-00406	Human Vascularized Spinal Cord Organoid Device for Drug Discovery after traumatic injury	Zaida Alvarez	FUNDACIÓ INSTITUT DE BIOENGINYERIA DE CATALUNYA	Fundación Hospital Nacional de Parapléjicos para a Investigación y la Integración; Universitat de Barcelona; Institut d´Investigació Biomèdica de Bellvitge (IDIBELL); Fundación del Lesionado Medular	Enabling Technologies	HR Consortium	999.559,03
HR25-00415	Brain Integrative spatial data to generate new engineered 3D cerebral malaria models and treatments	Maria Bernabeu	Laboratorio Europeo de Biología Molecular (EMBL)	University of Glasgow	Infectious disease	HR Consortium	996.910,04
HR25-00427	The role of telomere transcription and TERRA in repairing broken telomeres in human cancer cells	Claus Maria Azzalin	FUNDACAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINE	N/A	Oncology	HR Single Organization	499.950,00
HR25-00453	VirusAwareScopes: Machine Learning-Driven Adaptive Microscopy for Long-Term Viral Infection Studies	Ricardo Henriques	Universidade Nova de Lisboa	N/A	Enabling Technologies	HR Single Organization	499.833,52
HR25-00456	Neural circuits underlying of the perception of other's emotions	Cristina Marquez	Universidade de Coimbra	CNRS - Centre National Recherche Scientifique	Neuroscience	HR Consortium	999.930,00
HR25-00467	Investigating Staphylococcus aureus Intracellular Lifestyle to Inform Antibiotic Selection	Ana Eulalio	Universidade de Coimbra	N/A	Infectious disease	HR Single Organization	473.902,70
HR25-00537	Early Risk Detection in Children with Genetic Predisposition to leukemia	ISIDRO SANCHEZ	FUNDACION DE INVESTIGACION DEL CANCER DE LA UNIVERSIDAD DE SALAMANCA	Agencia Estatal Consejo Superior de Investigaciones Científicas, M.P.; Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E.; Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús; Fundació Hospital Universitari Vall d´Hebron - Institut de Recerca (VHIR); FUNDACION UNO ENTRE CIEN MIL	Oncology	HR Consortium	1.000.000,00
HR25-00556	A Next-Generation Vaccine for Parkinson's Disease	Salvador Ventura	Universitat Autònoma de Barcelona (UAB)	Agencia Estatal Consejo Superior de Investigaciones Científicas, M.P.	Neuroscience	HR Consortium	628.288,00
HR25-00563	Innovative targeting of PAX5 in B-cell Acute Lymphoblastic Leukaemia	Alejandro Vaquero	Fundació Institut de Recerca Contra la Leucèmia Josep Carreras	Fundación Instituto de Investigación Sanitaria de Santiago de Compostela; FUNDACIÓN INTERNACIONAL JOSEP CARRERAS	Oncology	HR Consortium	989.800,00
HR25-00585	Anthracycline Legacy in Bone Marrow and Long-Term Cardiovascular Risks in Cancer Survivors	Borja Ibañez	Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III; Fundación para la Investigación Biomédica del Hospital Universitario La Paz	Cardiovascular and associated metabolic diseases	HR Consortium	999.500,00
HR25-00662	ARI-007, a CART anti-CD7 for patients with relapsed-refractory T cell acute lymphoid leukemia	Alvaro Urbano	Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer	Fundació Privada per a la Recerca i la Docència Sant Joan de Déu	Oncology	HR Consortium	996.024,00
HR25-00781	Therapeutic OligonUCleotides Activated by Nucleases: Targeted antibiotics for bacterial infections	Frank J. Hernandez	Universidad de Navarra - Universidad de Navarra	Medical University of Vienna	Infectious disease	HR Consortium	995.000,00
HR25-00804	Discovering moonlighting activities of antimicrobial resistance genes .	José Antonio Escudero	Universidad Complutense de Madrid	N/A	Infectious disease	HR Single Organization	499.570,00
HR25-00813	Improving gene therapy for life-threatening heart conditions	Juan Antonio Bernal	Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)	N/A	Cardiovascular and associated metabolic diseases	HR Single Organization	498.352,00
HR25-00814	Uncovering new mechanisms involved in the resolution of adipose tissue meta-inflammation	Josep A. Villena	Fundació Hospital Universitari Vall d´Hebron - Institut de Recerca (VHIR)	N/A	Cardiovascular and associated metabolic diseases	HR Single Organization	499.700,00
HR25-00861	Advancing Precision Oncology through the Tumor Microenvironment Analysis	Alexandre Calon	Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)	Universidad de Oviedo; Universidad de Granada; Consorcio para la explotación del Centro Nacional de Análisis Genómico	Oncology	HR Consortium	996.750,00
HR25-00880	Tuning neurons by controlling brain cell metabolism using MIcroenvironment sensitive Nanosystems	Ana Paula Gomes Moreira Pêgo	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação	Fundación Instituto de Investigación Sanitaria de Santiago de Compostela; Tel Aviv University; PT.AVC - União de Sobreviventes, Familiares e Amigos; Fundacio Ictus	Enabling Technologies	HR Consortium	999.563,80
HR25-00886	Study of the Impact of the Tumor Microenvironment on Immunotherapy in Glioblastoma	Joan Seoane	Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)	N/A	Oncology	HR Single Organization	497.992,96
HR25-00908	Discovery and Multidimensional Characterization of Novel Microglia Regulators in ALS	Cintia Roodveldt	Universidad de Sevilla	Fundación Canaria Instituto de Investigación Sanitaria de Canarias; Agencia Estatal Consejo Superior de Investigaciones Científicas, M.P.	Neuroscience	HR Consortium	770.000,00
HR25-00930	KCNB1-related developmental and epileptic encephalopathy: towards personalized therapies	ANTONIO FERRER	Universidad Miguel Hernández de Elche	Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús	Neuroscience	HR Consortium	797.525,00
HR25-00954	Targeting microexons and neural-related splicing programs to enhance in vitro beta cell maturation	Manuel Irimia	Universitat Pompeu Fabra (UPF)	Fundació Centre de Regulació Genòmica (CRG); Max-Delbrück-Center for Molecular Medicine (MDC)	Cardiovascular and associated metabolic diseases	HR Consortium	999.847,40
HR25-00965	Dopamine, impulsivity, and multi-scale, hierarchical control of behavior	Joseph Paton	Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud	N/A	Neuroscience	HR Single Organization	497.860,00
HR25-01094	Metabolic organ crosstalk in cancer-induced cachexia as a novel therapeutic approach	Miguel López	Universidad de Santiago de Compostela	Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)	Cardiovascular and associated metabolic diseases	HR Consortium	999.300,00
HR25-01153	Lipid droplets as immunometabolic mediators in mitochondrial disease encephalopathy	Albert Quintana	Universitat Autònoma de Barcelona (UAB)	N/A	Neuroscience	HR Single Organization	499.970,00
HR25-01192	Development of CAR T cell therapies against cancer-specific post-translational modifications	João Lacerda	FUNDACAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINE	N/A	Oncology	HR Single Organization	499.303,00

Projetos selecionados CaixaResearch Health call 2024

Code	Project Title	Project Leader	Host Organization	Partner Organizations	Thematic Area	Category	Budget (€)
HR24-00001	Exploiting host free fatty acids to sterilize Mycobacterium tuberculosis infections	Tiago Beites	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação	Radboud University	Infectious disease	HR Consortium	693,011.00
HR24-00042	A new Pathway to Modulate T cell Activity	Marc Veldhoen	Gulbenkian Institute of Molecular Medicine	Associação AccelBio	Infectious disease	HR Consortium	963,414.00
HR24-00056	Restoring vision by integrating optic nerve organoids in retinitis pigmentosa rat visual circuity	Pia Cosma	Fundació Centre de Regulació Genòmica (CRG)	Universidade do Minho	Neuroscience	HR Consortium	997,293.00
HR24-00150	Generating stress-resistant β-cell for cell replacement therapy	Lorenzo Pasquali	Universitat Pompeu Fabra (UPF)	Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH (Helmholtz Munich)	Cardiovascular and associated metabolic diseases	HR Consortium	981,616.00
HR24-00152	Generation of humanized organs from human iPS cells	Xabier Aranguren	Fundación para la Investigación Médica Aplicada (FIMA/CIMA)	Università degli Studi di Padova and Universidad de Murcia	Cardiovascular and associated metabolic diseases	HR Consortium	999,127.90
HR24-00174	Peptide-based systems as artificial compartments to diagnose non-Alzheimer Tauopathies diseases	Ana Pina	Universidade Nova de Lisboa	Universitat de Barcelona - Fundació Bosch i Gimpera and Centro Hospitalar Lisboa Occidental	Enabling Technologies	HR Consortium	999,994.87
HR24-00279	Mapping metastasis plasticity	Roger Gomis	Fundació Institut de Recerca Biomèdica (IRB Barcelona)	Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer	Oncology	HR Consortium	664,165.90
HR24-00288	Decoding trypanosome interactions with the host vasculature	Luisa Figueiredo	Gulbenkian Institute of Molecular Medicine	Universidade Católica Portuguesa	Infectious disease	HR Consortium	998,850.00
HR24-00298	Bacteria-based LCOR therapy in lung metastasis and rational design of co-stimulatory molecules	Luis Felipe Serrano	Fundació Centre de Regulació Genòmica (CRG)	Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)	Enabling Technologies	HR Consortium	1,000,000.00
HR24-00326	Engineering the mechanobiology of the immunocompetent tumor ecosystem	Xavier Trepat	Fundació Institut de Bioenginyeria de Catalunya	Fundació Institut de Recerca Biomèdica (IRB Barcelona) and Centre Internacional de Mètodes Numèrics a l'Enginyeria (CIMNE)	Enabling Technologies	HR Consortium	998,200.00
HR24-00341	LncRNAs modulating DNA damage and repair: towards novel therapies for hepatocellular carcinoma	Puri Fortes	Fundación para la Investigación Médica Aplicada (FIMA/CIMA)	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III and Consejo Superior de Investigaciones Científicas (CSIC)	Oncology	HR Consortium	999,203.20
HR24-00445	Redox Metabolism as an Achilles’ Heel in Malaria Drug Discovery	Ruth Pérez	Consejo Superior de Investigaciones Científicas (CSIC)	Justus-Liebig-Universität Gießen and Asociación Centro de Investigación Cooperativa en Biociencias-CIC bioGUNE	Infectious disease	HR Consortium	999,400.00
HR24-00446	Exploring the PERK/STING axis in Pathological Inflammatory Conditions	Philippe Pierre	Universidade de Aveiro	N/A	Cardiovascular and associated metabolic diseases	HR Single Organization	499,931.66
HR24-00447	Targeting the Seeds of Relapse in Colorectal Cancer: Residual Disease and the Fibroblast Niche	Eduard Batlle	Fundació Institut de Recerca Biomèdica (IRB Barcelona)	N/A	Oncology	HR Single Organization	499,400.00
HR24-00528	Protein Aggregation in the Malaria Parasite: What for?	Xavier Fernàndez	Fundació Institut de Bioenginyeria de Catalunya	Universitat de Barcelona and Nanyang Technological University	Infectious disease	HR Consortium	907,923.1
HR24-00578	New molecules harnessing targeted protein degradation for the treatment of Machado-Joseph disease	Patrícia Maciel	Universidade do Minho	Universidade do Porto; Ataxia UK and National Ataxia Foundation	Neuroscience	HR Consortium	999,026.16
HR24-00581	Mitochondrial metabolism, at the heart of disease	Guadalupe Sabio	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	Universitat de València; Universidad de Santiago de Compostela and Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)	Cardiovascular and associated metabolic diseases	HR Consortium	999,920.00
HR24-00585	Development of a Synthetic Viral-like Particle Delivery System for Precision In vivo Gene Therapy	Marc Güell	Universitat Pompeu Fabra (UPF)	N/A	Enabling Technologies	HR Single Organization	499,750.00
HR24-00604	Mito4Neuro: Integrative characterization of the mitochondrial DNA replisome in health and disease	Rafael Fernandez	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	Hospital 12 de Octubre Research Institute and Fundación IMDEA Nanociencia	Neuroscience	HR Consortium	900,300.00
HR24-00641	Mechanisms of progression and therapeutic approaches to prevent/reverse MASLD to MASH transition	Antonio Vidal	Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe	Consorcio Centro de Investigación Biomédica en Red	Cardiovascular and associated metabolic diseases	HR Consortium	999,959.3
HR24-00648	Spatiotemporal dynamics of organ-specific microenvironments in breast cancer metastasis	Ana Luisa Correia	Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud	Tel Aviv University	Oncology	HR Consortium	997,610.0
HR24-00672	Deep mutational scanning of SOD1 to map mechanisms of toxicity and test novel therapeutics	Benedetta Bolognesi	Fundació Institut de Bioenginyeria de Catalunya	The Royal Melbourne Hospital and University of Wollongong	Enabling Technologies	HR Consortium	981,070.19
HR24-00686	A High-Resolution Functional Genomics Approach to Inform Precision Medicine for Fungal Disease	Agostinho Carvalho	Universidade do Minho	Radboud university medical center Nijmegen and Fundación Universitaria San Pablo-CEU	Infectious diseases	HR Consortium	999,898.43
HR24-00788	Brain Inflammation in adrenoleukodystrophy: from drivers to treatments	Aurora Pujol	Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)	Fundació Institut de Recerca Contra la Leucèmia Josep Carreras; Universitat de Barcelona and Asociación Española Contra la Leucodistrofia	Neuroscience	HR Consortium	999,782.47
HR24-00927	Improving Brain Arteriovenous Malformation Cure with local Antioncogenic Nanoparticle Embolization	Marc Ribó	Fundació Hospital Universitari Vall d´Hebron - Institut de Recerca (VHIR)	Universitat de Barcelona; Consorcio Centro de Investigación Biomédica en Red and Fundació Institut Català de Nanociència i Nanotecnologia	Neuroscience	HR Consortium	998,684.72
HR24-00929	Novel regulators of gamma-delta T cell subset differentiation and activation in infection	Bruno Silva-Santos	Gulbenkian Institute of Molecular Medicine	N/A	Infectious disease	HR Single Organization	500,000.00
HR24-00968	Precision ImmuneNanoTherapy targeting tumor-immune-stroma interactions against pancreatic cancer	María Jesús Vicent	Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe	FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento and Tel Aviv University	Enabling technologies	HR Consortium	999,999.4
HR24-00980	DNA topology and topoisomerases during oncogenesis: mechanisms and therapeutic opportunities	Felipe Cortés	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	N/A	Oncology	HR Single Organization	499,000.00
HR24-01000	Uncovering resistance mechanism to CAR-T cells via deep learning in scRNA-seq for improved therapies	Felipe Prosper	Universidad de Navarra - Universidad de Navarra	Fundación para la Investigación Médica Aplicada (FIMA/CIMA) and Weizmann Institute of Science	Oncology	HR Consortium	991,550.00

Projetos selecionados CaixaResearch Health call 2023

Code	Project Title	Project Leader	Host Organization	Partner Organizations	Thematic Area	Category	Budget (€)
HR23-00050	Characterization of bacterial lipid rafts; inhibition of antibiotic resistance using anti-raft drugs	Daniel Lopez Serrano	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Infectious disease	HR Single Organization	494,300.00
HR23-0051	Establishment of a precision medicine pipeline to personalize the treatment of brain metastasis	Manuel Valiente	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	N/A	Oncology	HR Single Organization	499,988.60
HR23-0060	Deciphering relapse in B-cell acute lymphoblastic leukemia	Biola Javierre	Fundació Institut de Recerca Contra la Leucèmia Josep Carreras	Barcelona Supercomputing Center - Centro Nacional de Supercomputación (BSC-CNS); Fundació Josep Carreras contra la Leucemia	Oncology	HR Consortium	999,999.92
HR23-0090	Applying DNA and optical barcoding to study endothelial progenitor cells in physiology and disease	Mariona Graupera	Fundació Institut de Recerca Contra la Leucèmia Josep Carreras	Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC; Fundació Institut de Recerca Biomèdica (IRB Barcelona)	Cardiovascular and associated metabolic diseases	HR Consortium	999,918.00
HR23-0124	The role of defects in mitochondria-associated ER membranes (MAM) to Amyotrophic Lateral Sclerosis	Estela Area Gomez	Consejo Superior de Investigaciones Científicas (CSIC)	Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla; Institut De Recerca Biomedica De Lleida. Fundació Dr. Pifarre	Neuroscience	HR Consortium	803,000.00
HR23-0173	Registry-based randomized trial to determine the role of Oxygen in acute Pulmonary Embolism	David Jiménez	Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal	N/A	Cardiovascular and associated metabolic diseases	HR Single Organization	499,999.00
HR23-0221	ChaoTROPIC Antimicrobial Hybrids for Bacterial Penetration	Javier Montenegro	Universidad de Santiago de Compostela	Universidade Nova de Lisboa	Infectious disease	HR Consortium	984,050.00
HR23-0361	ROLE OF RANK IN MYELOID CELLS AND TUMOR DEVELOPMENT	Eva González Suárez	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	N/A	Oncology	HR Single Organization	499,993.63
HR23-0367	Lab-grown red cells for the transfusion management of vaso-occlusive crisis in sickle cell patients	Núria Nogués Gálvez	Banc de Sang i Teixits	University of Bristol	Enabling Technologies	HR Consortium	941,350.12
HR23-0373	Systems analyses to stop mosquito-borne virus transmission: from mechanisms to biological control	Juana Díez Antón	Universitat Pompeu Fabra (UPF)	N/A	Infectious disease	HR Single Organization	430,400.00
HR23-0380	The molecular regulation of T cell development in the thymus: Implications for infectious diseases	Nuno L. ALves	Instituto de Investigação e Inovação em Saúde (i3S)	N/A	Infectious disease	HR Single Organization	499,005.00
HR23-0383	Targeting Imidazole Propionate in atherosclerosis	David Sancho	Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC	Fundación KERTOR	Cardiovascular and associated metabolic diseases	HR Consortium	967,620.20
HR23-0392	Single cell mapping of tumor-immune coevolution in organ-specific breast cancer metastasis	Toni Celià-Terrassa	Hospital del Mar Resarch Institute	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III; Leiden University Medical Centre	Oncology	HR Consortium	999,868.30
HR23-0421	Multisite Smartphone-based Ecological Momentary Intervention for suicide prevention	Enrique Baca Garcia	Fundación Instituto de Investigación Sanitaria of the Fundación Jiménez Díaz	Universidad de Oviedo; Universidad Carlos III de Madrid; Instituto de Biomedicina de Sevilla - Hospital Universitario Virgen del Rocío; DSAS: DESPRÉS DEL SUÏCIDI - ASSOCIACIÓ DE SUPERVIVENTS; Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)	Neuroscience	HR Consortium	999,955.00
HR23-0442	The cell of origin of Pancreatic Cancer: novel opportunities for the early diagnosis and treatment	Elisa Espinet Hernández	Universitat de Barcelona	Fundación Instituto de Investigacion Sanitaria de Aragon; NOVA.ID.FCT - Associação Para a Inovação e Desenvolvimento da FCT; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL); ASOCIACIÓN CÁNCER DE PÁNCREAS	Oncology	HR Consortium	999,999.18
HR23-0484	Wireless Neural Guidance Device for Spinal Cord Injury Repair	Nuno Silva	Universidade do Minho	LABORATORIO IBERICO INTERNACIONAL DE NANOTECNOLOGIA	Enabling Technologies	HR Consortium	993,872.59
HR23-0499	Genetic variability in Plasmodium Liver Stage Schizogony	Maria Mota	Instituto de Medicina Molecular João Lobo Antunes	N/A	Infectious disease	HR Single Organization	499,999.50
HR23-0516	From metabolic space to neuronal space: mapping how nutrients affect brain function and behavior	Carlos Ribeiro	Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud	European Molecular Biology Laboratory	Neuroscience	HR Consortium	997,381.40
HR23-0558	Monkeypox virus cytokine decoy receptors: adaptation to human immune evasion and transmission	Antonio Alcamí	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Infectious disease	HR Single Organization	499,800.00
HR23-0560	Lipid droplets as key players in brain microgliosis after stroke	Anna M. Planas	Consejo Superior de Investigaciones Científicas (CSIC)	Tel Aviv University; Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer; Fundacio Ictus	Neuroscience	HR Consortium	996,675.00
HR23-0608	Deciphering the impact of Leukaemia on Immunological Fitness beyond disease	Nuno Rodrigues dos Santos	Instituto de Investigação e Inovação em Saúde (i3S)	Consejo Superior de Investigaciones Científicas (CSIC); University of Oxford	Oncology	HR Consortium	981,307.27
HR23-0611	Novel genetic and mechanistic studies of hypertrophic cardiomyopathy	José Luis de la Pompa	Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC	Universidad de Murcia; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)	Cardiovascular and associated metabolic diseases	HR Consortium	999,668.18
HR23-0679	Compact Analytical Tool for robust MALaria decentralized diagnosis and community surveillance	Eva Baldrich Rubio	Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)	Institut de Bioenginyeria de Catalunya; Consejo Superior de Investigaciones Científicas (CSIC)	Enabling Technologies	HR Consortium	989,940.75
HR23-0682	Blocking bacterial glycosyltransferases to circumvent antibiotic resistance	Didier Cabanes	Instituto de Investigação e Inovação em Saúde (i3S)	N/A	Infectious disease	HR Single Organization	499,950.00
HR23-0683	Initiation of immune responses by surveillance of homeostasis perturbations	Luís Ferreira Moita	Fundação Calouste Gulbenkian	N/A	Infectious disease	HR Single Organization	499,900.00
HR23-0718	DOSImetry monitor for FLASH therapy	Consuelo Guardiola	Consejo Superior de Investigaciones Científicas (CSIC)	Universidad de Santiago de Compostela; Institut Curie; Universidad de Sevilla	Enabling Technologies	HR Consortium	971,936.00
HR23-0749	Personalizing diagnosis and treatment for Familial Hypercholesterolaemia patients	Mafalda Bourbon	Instituto Nacional de Saúde Doutor Ricardo Jorge	University of Helsinki; Institut National de la Santé et de la Recherche Médicale - INSERM; Erasmus Medical Center; FH Europe	Cardiovascular and associated metabolic diseases	HR Consortium	999,912.00
HR23-0793	Cannabis and psychoses: decoding the link	Juan Pedro Bolaños	Universidad de Salamanca	Institut National de la Santé et de la Recherche Médicale - INSERM; Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)	Neuroscience	HR Consortium	994,100.00
HR23-0799	Weber's Law: A mechanistic window into sensory dysfunction in autism spectrum disorders	Alfonso Renart	Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud	N/A	Neuroscience	HR Single Organization	499,998.40
HR23-0837	Advanced MIcroscopy for the study of Dynamic innate immunity activation by immunoGENIC cell death	Francisco Sánchez Madrid	Universidad Autónoma de Madrid	Fundación para la Investigación Biomédica del Hospital de la Princesa; Consejo Superior de Investigaciones Científicas (CSIC)	Enabling Technologies	HR Consortium	696,852.50
HR23-0840	Inflammation in Cardiovascular diseases: Mitochondrial Fgr Kinase as a therapeutic target	José Antonio Enríquez Domínguez	Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC	N/A	Cardiovascular and associated metabolic diseases	HR Single Organization	498,000.00
HR23-0860	Unravelling pro-regenerative signaling modules in the injured brain	Christa Rhiner	Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud	Achucarro Basque Center for Neuroscience Fundazioa	Neuroscience	HR Consortium	899,298.20
HR23-0881	Immune regulation of skeletal muscle metabolic health and exercise response in aging	Pedro Sousa-Victor	Instituto de Medicina Molecular João Lobo Antunes	N/A	Cardiovascular and associated metabolic diseases	HR Single Organization	499,835.60

Projetos selecionados CaixaResearch Health call 2022

Code	Project Title	Project Leader	Host Organization	Partner Organizations	Thematic Area	Category	Budget (€)
HR22-00073	R-loop-mediated genome instability factors in cancer	Andrés Aguilera	Universidad de Sevilla	N/A	Oncology	Individual	500,000
HR22-00100	Using small-molecule inhibitors to explore the unique properties of the bacterial K+ machinery and its potential as an antibacterial target	João Morais Cabral	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação	N/A	Infectious disease	Individual	498,999
HR22-00123	Moving from reactive to proactive strategies for the prevention of the next West Nile virus outbreak in Andalucía	Jordi Figuerola	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Infectious disease	Individual	499,909.28
HR22-00172	(Epi)Genomic and microenvironment interactions driving evolution in chronic lymphocytic leukemia. Targets for clinical intervention	Elías Campo	Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	Fundación Universidad de Oviedo; Centre de Regulació Genòmica (CRG)	Oncology	Research Consortium	999,806.30
HR22-00189	Neuromorphic devices for adaptive real-time neuromodulation in brain electrical stimulation therapies	Paulo Aguiar	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação	Universidade do Porto; Consejo Superior de Investigaciones Científicas (CSIC); Centro Hospitalar Universitário do Porto, E.P.E.	Enabling Technologies	Research Consortium	965,888.78
HR22-00221	Antibody-mediated NMDA receptor encephalitis: symptoms, biomarkers, and mechanisms of the prolonged recovery stage	Josep Dalmau	Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	Fundació Privada per a la Recerca i la Docència Sant Joan de Déu	Neuroscience	Research Consortium	972,352.39
HR22-00253	Harnessing the adaptive immune response in vascular pathologies: towards the identification of new therapeutic avenues	Almudena R. Ramiro	Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC	Fundación Instituto de Investigación Sanitaria of the Fundación Jiménez Díaz	Cardiovascular and associated metabolic diseases	Research Consortium	750,042.40
HR22-00316	Understanding and promoting the growth and regenerative functions of blood vessels in heart disease	Rui Benedito	Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC	Centre de Regulació Genòmica (CRG); Fundació Institut de Recerca Contra la Leucèmia Josep Carreras; University Hospital RWTH Aachen	Cardiovascular and associated metabolic diseases	Research Consortium	999,948.04
HR22-00394	Epigenetic basis of gene-environment interactions underlying variation in Cognitive capabilities and their Decline with Age	Angel Barco	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Neuroscience	Individual	498,000
HR22-00395	Vascularized lymphoma on-chip: a multifaceted tool for translational research	Patricia Perez	Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	European Molecular Biology Laboratory Barcelona	Enabling Technologies	Research Consortium	499,871.26
HR22-00402	Potentiating cancer immunotherapy by inhibiting the NMD quality-control pathway guided by genetic markers	Fran Supek	Fundació Institut de Recerca Biomèdica (IRB Barcelona)	Universitat Pompeu Fabra (UPF)	Oncology	Research Consortium	998,900.50
HR22-00405	Accelerated evolution of high-weight protein complexes for precision antimicrobials	Alfonso Jaramillo	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Enabling Technologies	Individual	482,730
HR22-00447	Metabolic communication between immune cells orchestrates the response to pathogens	Nuria Martínez	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Infectious disease	Individual	496,685.86
HR22-00529	Novel mutational mechanisms of somatic retrotransposition in the context of the 3D cancer genome	Jose Tubio	Universidad de Santiago de Compostela	N/A	Oncology	Individual	495,476.89
HR22-00533	A DIRect QuanTitative assessment of Heart disease with magnetic resonance imaging	Teresa Matias	Centro De Ciências Do Mar Do Algarve	Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC; Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento; Universidad de Valladolid	Cardiovascular and associated metabolic diseases	Research Consortium	998,472.90
HR22-00551	Endothelial Cells as rheostats for Age-Related Diseases	Claudio Franco	Instituto de Medicina Molecular	N/A	Cardiovascular and associated metabolic diseases	Individual	499,818.88
HR22-00569	NRF2 as a novel therapeutic target in early and intermediate age-related macular degeneration	Miguel Seabra	Universidade Nova de Lisboa	Centro Investigation Biomedica en Redes Neurodegenerativas - CIBERNED	Neuroscience	Research Consortium	985,013
HR22-00602	New nanotechnological therapy for Parkinson's disease: nose to brain delivery of GBA-polymer nanoconjugates	Marta Martínez	Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)	Universitat Autònoma de Barcelona (UAB); Centro de Investigación Príncipe Felipe	Neuroscience	Research Consortium	599,723.00
HR22-00668	Uncovering the Differentiation Determinants and Dynamics of Congenital Susceptibility to Infections	Esteban Ballestar	Fundació Institut de Recerca Contra la Leucèmia Josep Carreras	Fundació Josep Carreras contra la Leucemia	Infectious disease	Individual	477,722.19
HR22-00681	Epigenetic regulation of host immunity and neurological long-term consequences of SARS-CoV-2 infection	Christian Brander	Institut de Recerca de la Sida "la Caixa" - IRSICAIXA	Centre de Regulació Genòmica (CRG); Fundació FLS de lluita contra la sida, les malalties infeccioses i la promoció de la salut i la ciencia; Institut De Recerca I Tecnología Agroalimentaria	Infectious disease	Research Consortium	999,580
HR22-00702	Multifunctional nano-immunotherapy against breast brain metastases	Helena Florindo	FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento	Tel Aviv University	Enabling Technologies	Research Consortium	853,405.70
HR22-00722	The BioPlaTTAR Platform for the Tailored and Rapid Development of Antiviral Biopharmaceuticals	Cláudio Manuel Soares	Universidade Nova de Lisboa	Instituto de Medicina Molecular; Fundação Calouste Gulbenkian; Consejo Superior de Investigaciones Científicas (CSIC)	Enabling Technologies	Research Consortium	1,000,000
HR22-00732	Somatic mutations and clonal hematopoiesis as predictors and drivers of heart failure progression	José Javier Fuster	Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC	Fundació Institut de Recerca Contra la Leucèmia Josep Carreras; Fundació Institut d’Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP); Fundació Josep Carreras contra la Leucemia; Fundació Institut de Recerca Biomèdica (IRB Barcelona); Fundación para la Formación e Investigación Sanitarias de la Región de Murcia	Cardiovascular and associated metabolic diseases	Research Consortium	998,043.28
HR22-00741	Harnessing germinal centre regulation for improved vaccines	Luis Graca	Instituto de Medicina Molecular	Cultivamos Cultura	Infectious disease	Individual	499,952
HR22-00754	Role of diet-derived retinoids in CD8αα intraepithelial lymphocytes and intestinal defence at early-life	Manuela Ferreira	Universidade de Coimbra	N/A	Infectious disease	Individual	408,077.71
HR22-00776	Role of cellular senescence during breast cancer progression and treatment	Joaquín Arribas	Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)	N/A	Oncology	Individual	500,000
HR22-00778	Circuit mechanisms for associating high-order cortical activity with expected sensory representations in health and desease	Leopoldo Petreanu	Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud	N/A	Neuroscience	Individual	499,976.40
HR22-00799	T cell acute lymphoblastic leukemia: Origin & Relapse	Vera Sofia Correia Martins	Fundação Calouste Gulbenkian	Universität Ulm	Oncology	Research Consortium	681,932.54
HR22-00813	Highly efficient technology for clean and safe air: development of advanced air purifiers to inactivate pathogens in aerosols	Miguel A. Bañares	Consejo Superior de Investigaciones Científicas (CSIC)	Fundación para la Investigación Biomédica del Hospital Universitario La Paz; Hospital Universitario Severo Ochoa	Enabling Technologies	Research Consortium	997,000
HR22-00854	The dynamic membrane traffic at the neuronal synapse: Endosomal sub-compartments in health and disease	Ira Milosevic	Universidade de Coimbra	N/A	Neuroscience	Individual	492,837.85
HR22-00879	Whole-systems Analysis of the Microbiome-Metabolome Crosstalk for Biomarker Discovery and Therapy of Respiratory Fungal Diseases	Cristina Cunha	Universidade do Minho	N/A	Infectious disease	Individual	499,646.79
HR22-00890	Modulating nucleolar activity and stress responses as a therapeutic strategy in ALS	Oscar Fernandez-Capetillo	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	N/A	Neuroscience	Individual	498,850

Projetos selecionados CaixaResearch Health call 2021

Code	Project Title	Project Leader	Host Organization	Partner Organizations	Thematic Area	Category	Budget (€)
HR21-00046	Decoding the paracrine control of metabolic fitness by endothelial nutrient signaling	Alejo Efeyan	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	Cardiovascular and associated metabolic diseases	Research Consortium	992.580,60
HR21-00386	High precision cardioprotective therapy: a photoswitchable approach to reduce the extension of myocardial infarction	Amadeu Llebaria	Consejo Superior de Investigaciones Científicas (CSIC)	Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) - Purdue University, West Lafayette, IN - GICOR	Cardiovascular and associated metabolic diseases	Research Consortium	999.779,50
HR21-00430	Phospholipid biosynthesis and transport between endoplasmic reticulum and mitochondria: understanding their essential role in liver disorders	Antonio Zorzano	Fundació Institut de Recerca Biomèdica (IRB Barcelona)	Universitat de Barcelona - Fundació Institut d'Investigació Sanitària Pere Virgili	Cardiovascular and associated metabolic diseases	Research Consortium	997.014
HR21-00233	Loss of Triadin impairs cardiac proteostasis disclosing pathophysiological complexity in Catecholaminergic Polymorphic Ventricular Tachycardia Type 5	Silvia Giuliana Priori	Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC	N/A	Cardiovascular and associated metabolic diseases	Individual	496.100
HR21-00793	RIPK3 biology and targeting in metabolic liver disease	Cecilia Rodrigues	FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento	N/A	Cardiovascular and associated metabolic diseases	Individual	320.000,07
HR21-00375	Massively parallel mutagenesis to understand, predict and prevent amyloid nucleation in neurodegenerative diseases	Ben Lehner	Centre de Regulació Genòmica (CRG)	Institut de Bioenginyeria de Catalunya	Enabling technologies	Research Consortium	994.048,90
HR21-00925	Development of enabling technologies for T-cell immunotherapy of solid tumors	Sonia Guedán	Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	Asociación Centro de Investigación Cooperativa en Biociencias (CIC bioGUNE) - Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)	Enabling technologies	Research Consortium	963.488
HR21-00410	Graphene aptasensor bioelectronics: a neural interface for neurotransmission probing in neurological disorders	Pedro Alpuim	Laboratorio Iberico Internacional de Nanotecnologia	Universidade do Minho - Consejo Superior de Investigaciones Científicas (CSIC)	Enabling technologies	Research Consortium	997.692,19
HR21-00208	Enzyme propelled nanobots as efficient nanotech platform for bladder cancer therapy	Samuel Sánchez	Institut de Bioenginyeria de Catalunya	Asociación Centro de Investigación Cooperativa en Biomateriales - Universitat Autònoma de Barcelona (UAB) - Fundació Clínic per a la Recerca Biomèdica -Fundacio Catalunya-La Pedrera Fundacio Especial - Universitat de Barcelona - Fundació Bosch i Gimpera	Enabling Technologies	Research Consortium	997.946,50
HR21-00415	A multidisciplinary approach to understand host and pathogen interactions to develop new strategies to target tuberculosis	Margarida Saraiva	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação	Consejo Superior de Investigaciones Científicas (CSIC) - Francis Crick Institute	Infectious diseases	Research Consortium	998.404
HR21-00848	Whole-organism vaccines against P. falciparum and P. vivax malaria with enhanced efficacy and scope	Miguel Prudêncio	Instituto de Medicina Molecular	Leiden University Medical Centre - US Naval Medical Research Unit 6	Infectious diseases	Research Consortium	997.453,50
HR21-01020	Neuron-astrocyte signaling in depression: learning from astrocytes how to effectively treat depression	João Filipe Oliveira	Universidade do Minho	N/A	Neuroscience	Individual	499.478,45
HR21-00171	Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria	Hernando A. del Portillo	Institut de Salut Global de Barcelona (ISGlobal)	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação - Universitat de Barcelona - Mahidol University	Infectious diseases	Research Consortium	996.930,57
HR21-00368	Molecular dissection of TNF-mediated pathogenic macrophage necrosis in tuberculosis	Francisco Jose Roca Soler	Universidad de Murcia	N/A	Infectious diseases	Individual	460.252,80
HR21-00737	Acquisition of antifungal resistance in pathogenic Candida spp.: evolutionary paths, fitness trade-offs, and interplay with the immune system	Toni Gabaldón	Fundació Institut de Recerca Biomèdica (IRB Barcelona)	N/A	Infectious diseases	Individual	499.244
HR21-00622	In vivo reprogramming to rescue alterations in Huntington’s disease	Josep M. Canals	Universitat de Barcelona - Fundació Bosch i Gimpera	Lund University - Cardiff University - Institute of Molecular Biotechnology (IMBA)- European Huntington's Disease Network	Neuroscience	Research Consortium	994.890
HR21-00259	From GFAP mutations in astrocytes to neurodegeneration: exploring a lipid-protein oxidation pathway	Dolores Pérez-Sala	Consejo Superior de Investigaciones Científicas (CSIC)	Brain Center, University Medical Center Utrecht -University of Copenhagen - University of Gothenburg -Institut De Recerca Biomedica De Lleida. Fundació Dr. Pifarre	Neuroscience	Research Consortium	1.000.000
HR21-00824	A strategy to guide and promote spinal and visual axons regeneration after injury	Eloísa Herrera	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Neuroscience	Individual	495.500
HR21-01136	Deep learning of a hippocampal memory code in health and disease	Liset Menéndez de la Prida	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Neuroscience	Individual	491.700
HR21-01208	RBM10, a novel splicing regulator and tumor suppressor: from mechanisms to therapies	Juan Valcárcel	Centre de Regulació Genòmica (CRG)	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	Oncology	Research Consortium	816.239,46
HR21-00176	Understanding lncRNAs in replicative stress and colorectal cancer: from cancer biology to single-molecules	Maite Huarte	Fundación para la Investigación Médica Aplicada (FIMA/CIMA)	Consejo Superior de Investigaciones Científicas (CSIC) - Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	Oncology	Research Consortium	995.200
HR21-00761	IL7R in lung cancer development, metastasis and resistance to immune checkpoint inhibitor therapy	João Barata	Instituto de Medicina Molecular	Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre - Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	Oncology	HR Consortium	999.962
HR21-00083	Interleukin-8 and neutrophil extracelular traps as actionable hurdles for cancer immunotherapy	Ignacio Melero	Fundación para la Investigación Médica Aplicada (FIMA/CIMA)	N/A	Oncology	Individual	498.850
HR21-00020	Cracking the cancer tubulin code for precision oncology	Helder Maiato	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação	N/A	Oncology	Individual	499.983
Projetos premiados em colaboração com a Fundação Luzon
HR21-00931	Targeting TDP-43 with protein kinase inhibitors: a effective and measurable therapy for ALS	Ana Martinez	Consejo Superior de Investigaciones Científicas (CSIC)	FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento -Universidad Complutense de Madrid	Neuroscience	Research Consortium	500.000
Projetos premiados em colaboração com a Fundação para a Ciência e a Tecnologia, I.P. no âmbito da "Iniciativa Ibérica de Investigação e Inovação Biomédica, i4b"
HR21-01212	Decoding the non-code of beta-cells cis-regulation	Jose Bessa	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação	N/A	Cardiovascular and associated metabolic diseases	Individual	499.355
HR21-00605	Protecting the brain from metastatic breast cancer	Miguel Castanho	Instituto de Medicina Molecular	Asociación Instituto Biodonostia - FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento - Asociación Centro de Investigación Cooperativa en Biomateriales	Enabling Technologies	Research Consortium	632.841
HR21-00533	A flexible platform for generating synthetic virus to control infectious diseases	Joana Azeredo	Universidade do Minho	N/A	Infectious diseases	Individual	492.460,48
HR21-01077	Regulation of prefrontal cortical synaptic function and behavior by chronic stress-induced microRNA-186-5p	Paulo Pinheiro	Centro de Neurociências e Biologia Celular	N/A	Neuroscience	Individual	492.304,48
HR21-00077	Regulatory RNA–protein interactions at telomeres in healthy cells and during malignant transformation	Claus Maria Azzalin	Instituto de Medicina Molecular	N/A	Oncology	Individual	495.792

Projetos selecionados CaixaResearch Health call 2020

Code	Project Title	Project Leader	Host Institution	Partner Institutions	Thematic Area	Category	Budget (€)
HR20-00493	Function of a novel program of islet microexons in beta cell development, insulin secretion and diabetes	Manuel Irimia	Centre de Regulació Genòmica (CRG)	N/A	Cardiovascular and metabolic diseases	Individual	499.592
HR20-00075	Flow-driven inflammation and arterial wall remodeling in atherosclerosis: mechanisms and therapeutic potential	Miguel Ángel del Pozo	Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC	Yale University, New Haven, CT, Aarhus University, Asociación Centro de Investigación Cooperativa en Biomateriales	Cardiovascular and metabolic diseases	Research Consortium	999.987
HR20-00322	RNA mis-splicing in hypertrophic cardiomyopathy: opportunities for diagnosis and therapy	Maria Carmo-Fonseca	Instituto de Medicina Molecular	Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento, Associação para Investigação e Desenvolvimento da Faculdade de Medicina	Cardiovascular and metabolic diseases	Research Consortium	986.964
HR20-00051	Succinate/SUCNR1 axis: a novel target for anti-obesity therapies	Sonia Fernandez	Fundació Institut d'Investigació Sanitària Pere Virgili	Universidad de Santiago de Compostela, Institut D'Investigació Biomèdica De Girona (IDIBGI)	Cardiovascular and metabolic diseases	Research Consortium	998.902
HR20-00369	Enabling technologies to map nuclear mechanosensing: from organoids to tumors	Xavier Trepat	Institut de Bioenginyeria de Catalunya	Netherlands Cancer Institute	Enabling technologies	Research Consortium	984.630
HR20-00800	Deep Learning to Dissect the Interaction between Leukemic Cells and the Ageing Niche	M. Carolina Florian	Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)	Universität Ulm	Enabling technologies	Research Consortium	817.045
HR20-00637	BioPrinted hydROgel MicrofluIdicS to mimic patient-specific tumor mEtastatic microenvironment	Elena Martinez	Institut de Bioenginyeria de Catalunya	Laboratorio Ibérico Internacional de Nanotecnologia, Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)	Enabling technologies	Research Consortium	981.675
HR20-00428	Heterogenous protein acylation and cancer	Gemma Triola	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Enabling technologies	Individual	341.242
HR20-00218	Enhancing Tissue-Specific Immune Microenvironments for the Cure of HIV	María José Buzón	Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)	Consejo Superior de Investigaciones Científicas (CSIC), Institut de Recerca de la Sida "la Caixa" - IRSICAIXA	Infectious diseases	Research Consortium	699.134
HR20-00361	Mechanism and function of epitranscriptomic poly(A) tail modifications in African trypanosomes	Luisa Figueiredo	Instituto de Medicina Molecular Joao Lobo Antunes	N/A	Infectious diseases	Individual	499.400
HR20-00635	Coping with unpredictability: regulatory plasticity as an adaptation strategy in the human malaria parasite	Elena Gomez-Díaz	Consejo Superior de Investigaciones Científicas (CSIC)	University of Glasgow, University of Sciences, Techniques and Technologies of Bamako (USTTB), Malaria Rsearch and Training Center	Infectious diseases	Research Consortium	999.548
HR20-00584	Discovery of new antiparasitic drug candidates and innovative modes of actions from Microbial Natural Products	Olga Genilloud	Fund. Centro de Excelencia en Inv. de Medicamentos Innovadores en Andalucia	Drugs for Neglected Diseases Initiative (DNDi), Institut Pasteur korea	Infectious diseases	Research Consortium	995.251
HR20-01000	Encoding reward and aversion in the mammalian brain: the overlooked role of endogenous opioids	Ana Joao Rodrigues	Universidade do Minho	N/A	Neuroscience	Individual	499.788
HR20-00083	Restoration of sensory circuits based on glia-to-neuron reprogramming	Guillermina López-Bendito	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Neuroscience	Individual	499.000
HR20-00081	Amino acid transporter structure to target glutamate transmission in neuro diseases	Manuel Palacin	Fundació Institut de Recerca Biomèdica (IRB Barcelona)	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	Neuroscience	Research Consortium	428.500
HR20-00896	Mitochondrial transcription as a trigger for neurodegenation	Albert Quintana	Universitat Autònoma de Barcelona (UAB)	N/A	Neuroscience	Individual	500.000
HR20-00714	A cortical pathogenesis of Parkinson's disease	Guglielmo Foffani	Fundación de Investigación HM Hospitales	N/A	Neuroscience	Individual	500.000
HR20-00465	Immunomodulatory drivers in melanoma progression and therapy response	Marisol Soengas	Fund. del Sector Público Estatal Centro Nacional de Inv. Oncológicas Carlos III	N/A	Oncology	Individual	481.597
HR20-00164	A new functional paradigm for RhoA gene mutations in peripherial Tcell Lymphoma: Functional and Clinical implications	Xose R. Bustelo	Fundación de Investigación del Cancer	N/A	Oncology	Individual	498.300
HR20-00871	Gene Regulatory NETworks in NORmal and MALignant Hematopoiesis-Identification and Targeting (GR-NET NORMAL-HIT)	Felipe Prosper	Universidad de Navarra	Fundación para la Investigación Médica Aplicada (FIMA/CIMA), Fundación Miguel Servet - Navarrabiomed, University of Cambridge	Oncology	Research Consortium	999.410
HR20-00411	Virtual patient derived xenografts for tumor treatment	Luciano Di Croce	Centre de Regulació Genòmica (CRG)	Fundació Sant Joan de Déu	Oncology	Research Consortium	990.160
Proyectos galardonados en colaboración con la Fundación Luzón
HR20-01109	Brain Liquid Biopsy for Alzheimer disease and neurodegenerative disorders	Maite Mendioroz	Fundación Miguel Servet - Navarrabiomed	N/A	Neuroscience	Individual	482.847
Proyectos galardonados en colaboración con la Fundação para a Ciência e a Tecnologia, I.P. en el marco de la “Iniciativa Ibérica de Investigaçao e Inovaçao Biomédica, i4b"
HR20-00249	Diamond Photonics Platforms for Synaptic Connectivity Assessment in Healthy and Parkinson Disease Neuronal Models	Jana B. Nieder	Laboratorio Ibérico Internacional de Nanotecnologia	Universidade do Minho, Universidade de Aveiro	Enabling technologies	Research Consortium	999.981
HR20-00841	Unravelling pulmonary neuroimmune circuits during infection	Henrique Veiga-Fernandes	Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud	N/A	Infectious disease	Individual	499.950
HR20-00904	Potassium channel dysfunction in models of neurodevelopmental disorders	Ana Luisa Carvalho	Centro de Neurociências e Biologia Celular	IINS - Interdisciplinary Institute for Neuroscience, CNRS 5297, University of Bordeaux	Neuroscience	Research Consortium	782.000

Projetos selecionados CaixaResearch Health call 2019

Code	Project Title	Project Leader	Host Institution	Partner Institutions	Thematic Area	Category	Budget (€)
HR1818-00120	Mapping the pathogenesis of vascular malformations	Mariona Graupera	Institut d'Investigació Biomèdica de Bellvitge	Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.), Fundación Privada Hospital de la Santa Creu i Sant Pau, Fundació Sant Joan de Déu	Cardiovascular and metabolic diseases	Research Consortium	755.018
HR1818-00068	Nitric Oxide signaling and proteoglycans in Marfan syndrome’s aortopathy: mechanisms and new therapeutic targets	Juan Miguel Redondo Moya	Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)	Consejo Superior de Investigaciones Científicas	Cardiovascular and metabolic diseases	Research Consortium	500.000
HR1818-00304	Dysfunction of Ion Channel Complexes in Inheritable Cardiac Diseases	José Jalife	Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)	N/A	Cardiovascular and metabolic diseases	Individual	499.895
HR1818-00100	Hypothalamic control of gut function and microbiota composition: implications for energy balance regulation	Marc Claret Carles	Institut d'Investigacions Biomèdiques August Pi i Sunyer	Université catholique de Louvain (UCLouvain), Universidad de Santiago de Compostela	Cardiovascular and metabolic diseases	Research Consortium	972.183
HR1818-00359	Origin and functions of the tumor stroma in metastatic colorectal cancer	Eduard Batlle	Fundació Institut de Recerca Biomèdica (IRB Barcelona)	N/A	Oncology	Individual	499.997
HR1818-00069	Next-generation CAR-DOT cells for allogeneic adoptive cancer immunotherapy	Bruno Miguel de Carvalho Silva-Santos	Instituto de Medicina Molecular	Josep Carreras Leukemia Research Institute (JCLRI)	Oncology	Research Consortium	999.997
HR1818-00302	Post-transcriptional gene regulation reprogramming in obesity-driven liver cancer	Raúl Méndez	Fundació Institut de Recerca Biomèdica (IRB Barcelona)	N/A	Oncology	Individual	499.883
HR1818-00256	Defining The Role of Exosome-Secreted Micropeptides in Pancreatic Cancer	Maria Abad	Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)	Fundación Centro Nacional de Investigaciones Oncológicas Carlos III, Champalimaud Foundation	Oncology	Research Consortium	694.600
HR1818-00023	Targeting Telomeres in Cancer	Maria A. Blasco	Fundación Centro Nacional de Investigaciones Oncológicas Carlos III	N/A	Oncology	Individual	489.100
HR1818-00589	Sensitizing pancreatic cancer to immunotherapy with multimodal precision nanomedicines	Maria Jesús Vicent Docón	Centro de Investigación Príncipe Felipe	Facultade de Farmacia da Universidade de Lisboa, Sackler Faculty of Medicine. Tel Aviv University	Enabling technologies	Research Consortium	985.042
HR1818-00501	Light-regulated drugs to restore sight	Pau Gorostiza Langa	Institut de Bioenginyeria de Catalunya	Universidad Miguel Hernández de Elche (UMH), Consejo Superior de Investigaciones Científicas, Barcelona Macula Foundation Research (BMF), Universidad de Alcalá (UAH)	Enabling technologies	Research Consortium	498.051
HR1818-00336	Community-Driven Big Data Intelligence to Fight Mosquito-Borne Disease	Frederic Bartumeus Ferré	Consejo Superior de Investigaciones Científicas	Universitat Pompeu Fabra, Max Planck Institute for Demographic Research (MPDIR), National Center of Epidemiology (CNE). CIBERESP/ISCIII., Centre for Ecological Research and Forestry Applications (CREAF), Agència de Salut Pública de Barcelona (ASPB),Agencia de Salut Pública de Catalunya (ASPCAT). Generalitat de Catalunya, Centro de Coordinación de Alertas y Emergencias Sanitarias (CCAES)	Enabling technologies	Research Consortium	999.920
HR1818-00313	Adaptive Retinal Implant Technology for Vision Restoration	Jose Antonio Garrido Ariza	Fundació Institut Català de Nanociència i Nanotecnologia	Institut de Física d'Altes Energies (IFAE), The Institute of Photonic Sciences (ICFO), Barraquer Foundation (BF), Institut de la Vision (Sorbonne Université)	Enabling technologies	Research Consortium	999.715
HR1818-00058	Bacterial lung chassis for treating human lung infectious diseases	Luis Serrano Pubul	Fundació Centre de Regulació Genòmica	Institut d'Investigacions Biomèdiques August Pi i Sunyer	Infectious diseases	Research Consortium	999.528
HR1818-00469	Locking cells against Ebola virus	Carmen Gil	Consejo Superior de Investigaciones Científicas	Instituto de Investigación Biomédica Hospital 12 de Octubre (Imas12), Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Bernhard Nocht Institute for Tropical Medicine	Infectious disease	Research Consortium	995.068
HR1818-00267	Dissecting the initial molecular events that trigger sexual conversion and transmission in malaria parasites	Alfred Cortés Closas	Barcelona Institute for Global Health (ISGlobal)	N/A	Infectious diseases	Individual	499.400
HR1818-00104	Enhancing Tissue Resident Immunity	Marc Veldhoen	Instituto de Medicina Molecular	N/A	Infectious diseases	Individual	497.158
HR1818-00155	Exosome targeting of the hypothalamus: a novel strategy for the treatment of obesity	Miguel Antonio López Pérez	Universidad de Santiago de Compostela	N/A	Neuroscience	Individual	448.300
HR1818-00026	DUbbing Language-therapy CINEma-based in Aphasia post-Stroke. A feasibility cross-over pilot-trial	Blanca Fuentes Gimeno	Hospital Universitario la Paz	Universidad Pontificia de Comillas, Afasia Activa	Neuroscience	Research Consortium	308.066
HR1818-00178	Dyslexia and the thalamus: Integrating anatomy and function in a mechanistic account of the reading brain	Manuel Francisco Carreiras Valiña	Asociacion Basque Center on Cognition, Brain and Language	N/A	Neuroscience	Individual	500.000
HR1818-00452	Modulation of Tau seeding and pathology in tauopathies by BBB-nanocarriers, epitope selective vaccination and ectoPrP Tau receptor bodies	José Antonio Del Río Fernández	Institut de Bioenginyeria de Catalunya	Institut d'Investigació Biomèdica de Bellvitge, Institute for Research in Biomedicine (IRB Barcelona), Universitat de Barcelona and Institute of Complex Systems (UBICS)	Neuroscience	Research Consortium	763.002
HR1818-00007	Dynamics of the neural, metabolomic and neuropsychological signatures underlying the adaptations for motherhood during pregnancy	Oscar Vilarroya Oliver	Universitat Autònoma de Barcelona	Fundació Institut Mar d'Investigacions Mèdiques, Instituto de Investigación Sanitaria Gregorio Marañón , University of Lleida-IRBLleida, Reproductive Medicine Service at Dexeus Women Health	Neuroscience	Research Consortium	972.414
Projetos premiados em colaboração com a Fundação Luzon
HR1818-000341	A potential metabolic-targeted therapeutic for Amyotrophic lateral sclerosis (ALS): Leptin	Carmen Maria Fernandez-Martos	Fundación Hospital Nacional de Parapléjicos	San Pablo University, King´s College London and Wicking Dementia Centre/University of Tasmania	Neuroscience	Research Consortium	499979
Projetos premiados em colaboração com a Fundação para a Ciência e a Tecnologia, I.P. no âmbito da "Iniciativa Ibérica de Investigação e Inovação Biomédica, i4b"
HR1818-00187	Targeting induced-senescent cells: a novel approach to promote spinal cord regeneration in mammals	Leonor Saúde	Instituto de Medicina Molecular	N/A	Neuroscience	Individual	444048
HR1818-00502	Metabolic Reprograming In Sepsis	Miguel Che Parreira Soares	Fundação Calouste Gulbenkian	Universitätsklinikum Jena, Center for Sepsis Control and Care, Thüringen (Germany)	Infectious disease	Research Consortium	500000

Projetos selecionados CaixaResearch Health call 2018

Code	Project Title	Project Leader	Host Institution	Partner Institutions	Thematic Area	Category	Budget (€)
HR17- 00016	Readying immune cells prior to disease-inducing encounters	Francisco Sánchez-Madrid	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	N/A	Infectious disease	A	499.731
HR17- 00040	Understanding muscle regenerative decline with aging	Pura Muñoz-Cánoves	Universitat Pompeu Fabra (UPF)	N/A	Other biomedical areas	A	496.630
HR17- 00092	Metastasis Cell Fate Mapping	Roger Gomis Cabré	Institute for Research in Biomedicine (IRB)	N/A	Oncology	A	489.400
HR17- 00094	Eradicating prostate cancer metastasis before clinical manifestation	Arkaitz Carracedo	CIC bioGUNE	University of Cambridge (UK), Fundação Champalimaud (Lisboa), CIC biomaGUNE, Basurto Hospital	Oncology	A	499.915
HR17- 00149	A Translational Model of Antibody-mediated Synaptic Disease: Symptoms, Neuronal Circuits, and the Mechanisms of Memory Loss and Recovery	Josep Dalmau Obrador	Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	N/A	Neuroscience	A	498.718
HR17- 00199	Towards a universal therapeutic vaccine against chronic virus infections	Andreas Meyerhans	Universitat Pompeu Fabra (UPF)	IrsiCaixa	Infectious disease	A	484.316
HR17- 00221	Genomic and epigenomic drivers of disease evolution in chronic lymphocytic leukemia. Targets for clinical intervention	Elías Campo	Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	Universidad de Oviedo (UNIOVI), Barcelona Supercomputing Center (BSC)	Oncology	B	999.270
HR17- 00231	Regenerating photoreceptors in human retinal organoids to establish a treatment for Retinitis Pigmentosa	Maria Pia Cosma	Fundació Centre de Regulació Genòmica (CRG)	Institute for Bioengineering of Catalonia (IBEC), Instituto Barraquer	Neuroscience	A	499.519
HR17- 00232	Exploiting post-transcriptional regulation to uncover novel vulnerabilities of metastatic cells	Fátima Gebauer Hernández	Fundació Centre de Regulació Genòmica (CRG)	Centro Nacional de Investigaciones Oncológicas (CNIO)	Oncology	A	499.980
HR17- 00247	The antibody immune response during vascular remodeling	Almudena Rodríguez Ramiro	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Fundación Jimenez Diaz	Cardiovascular disease	A	499.963
HR17- 00264	Plasmodium Exploitation of Liver-specific Methionine Metabolism	Maria M. Mota	Instituto de Medicina Molecular (IMM), Lisboa	N/A	Infectious disease	A	499.950
HR17- 00267	Somatic Mutation-driven Clonal Hematopoiesis in Atherosclerosis - International Consortium	Valentí Fuster	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	University of Virginia (UVA)	Cardiovascular disease	B	999.896
HR17- 00268	Therapeutic targeting of MBNL microRNAs as innovative treatments for myotonic dystrophy	Ruben Artero-Allepuz	Universitat de Valencia	University of Oxford (UK), Institute for Bioengineering of Catalonia (IBEC), Institut IMAGINE (France), Institute Biodonostia, ASEM & Myotonic Dystrophy Foundation	Other biomedical areas	B	997.024
HR17- 00323	Optical dissection of cortical circuits for sensory expectations	Leopoldo Petreanu	Fundação Champalimaud, Lisboa	N/A	Neuroscience	A	499.708
HR17- 00409	Fighting Zika virus with antiviral peptides and conjugates translocating blood-placental and blood-brain barriers	David Andreu Martínez	Universitat Pompeu Fabra (UPF)	Instituto de Medicina Molecular (IMM), Instituto de Bioquímica Médica Leopoldo de Meis	Infectious disease	B	777.250
HR17- 00513	Modulation of age-dependent neuromelanin accumulation as a novel therapeutic strategy for Parkinson’s disease and brain aging	Miquel Vila Bover	Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)	N/A	Neuroscience	A	466.004
HR17- 00527	Therapeutic targeting of the neutrophil clock in cardiovascular disease	Andrés Hidalgo Alonso	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Universidad Complutense de Madrid (UCM), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	Cardiovascular disease	A	499.998
HR17- 00539	Identifying and testing the metabolites generated by two psychoactive gut bacteria to alter brain function and behavior	Carlos Vidal Ribeiro	Fundação Champalimaud, Lisboa	N/A	Neuroscience	A	463.694
HR17- 00595	Organismal role of the ER membrane complex: a conserved machinery required for membrane protein biogenesis.	Colin Adrain	Calouste Gulbenkian Foundation, Lisboa	Institute of Chemical and Biological Technology (ITQB-NOVA, Lisboa), Institute of Organic Chemistry and Biochemistry of the CAS (Czech Republic)	Other biomedical areas	B	960.769
HR17- 00627	Dissecting the functional role of the epicardium metabolism during heart development and repair after myocardial infarction	Ofelia María Martínez Estrada	Fundació Bosch i Gimpera (UB)	Fundació Hospital Universitari Vall d'Hebron Institut de Recerca (VHIR), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP)	Cardiovascular disease	A	438.100
Projetos premiados em colaboração com a Fundação Luzon
HR17- 00777	Activation of the resolution programs of inflammation as a novel therapeutic approach for the treatment of amyotrophic lateral sclerosis	Rubèn López Vales	Universitat Autònoma de Barcelona (UAB)	N/A	Neuroscience	A	500.000
Projetos premiados em colaboração com a Fundação para a Ciência e a Tecnologia, I.P. no âmbito da "Iniciativa Ibérica de Investigação e Inovação Biomédica, i4b"
HR17- 00523	Adenosine A2A receptors as a new opportunity to manage and detail the neurobiology of emotional distress	Rodrigo A. Cunha	Centro de Neurociências e Biologia Celular (CNC), Coimbra	N/A	Neuroscience	A	333.516
HR17- 00634	A Transdisciplinary Approach to the Identification of Personalized Biomarkers and Therapeutic Targets for Chronic Pulmonary Aspergillosis	Agostinho Albérico Rodrigues de Carvalho	Universidade do Minho	Fundación Universitaria San Pablo (CEU), Foundation for Research and Technology-Hellas, Jena University Hospital and Radboudumc	Infectious disease	B	999.027
HR17- 00601	Exosomal fat-liver axis in nonalcoholic fatty liver disease: function and targeting	Rui Eduardo Mota Castro	Universidade de Lisboa	Instituto Biodonostia, École polytechnique fédérale de Lausanne (EPFL) and CIC bioGUNE	Other biomedical areas	A	500.000
HR17- 00636	Sequential Cardiac Resynchronization Therapy	Joaquim Adelino Correia Ferreira Leite Moreira	Universidade do Porto	N/A	Cardiovascular disease	A	369.248

Resultados Health Research 2022

Caixaresearch Health 2022 information
Total Budget	23.148.611,88 €
Number of projects presented	547
Number of projects evaluated	546
Number of projects preselected	80
Number of projects selected	33
Success rate	6,04 %

Table 1: General information of CaixaResearch Health Call 2022.

Figure 1: Budget distribution by territory

Thematic Area	Proj. Evaluated	Proj. Preselected (peer review)		Proj. Selected (expert panel)
Cardiovascular and metabolic diseases	63	16	25,4 %	5	7,9 %
Neuroscience	163	16	9,8 %	8	4,9 %
Infectious diseases	72	16	22,2 %	8	11,1 %
Oncology	111	16	14,4 %	6	5,4 %
Enabling technologies	137	16	11,7 %	6	4,4 %
	546	80	14,7 %	33	6,0 %

Table 2: % of the preselected and selected projects compared to the submitted projects in each thematic area.

Thematic area		Proj. Evaluated	Proj. Preselected	Proj. Selected
Cardiovascular and metabolic diseases	Individual	22	5	1
	Research Consortium	41	11	4
	Total	63	16	5
Neuroscience	Individual	70	5	4
	Research Consortium	93	11	4
	Total	163	16	8
Infectious disease	Individual	33	7	7
	Research Consortium	39	9	1
	Total	72	16	8
Oncology	Individual	52	5	3
	Research Consortium	59	11	3
	Total	111	16	6
Enabling technologies	Individual	34	1	1
	Research Consortium	103	15	5
	Total	137	16	6
		549	80	33

Table 3: Number of Individual and Research Consortium projects compared to the total number of projects of each thematic area.

Resultados Health Research 2021

Health Research 2021 Call for Proposals - information
HR21 Budget	22.115.490,50 €
Number of projects presented	644
Number of projects evaluated	644
Number of projects preselected	70
Number of projects selected	30
Success rate	4,66 %

Table: General information of Health Research 2021 Call for Proposals.

Resultados Health Research 2020

Health Research 2020 Call for Proposals - information
HR20 Budget	15.200.128 €
Number of projects presented	602
Number of projects evaluated	600
Number of projects preselected	62
Number of projects selected	21
Success rate	3,50 %

Table: General information of Health Research 2020 Call for Proposals.

Resultados Health Research 2019

Health Research 2019 Call for Proposals - information
HR18 Budget	15.376.337 €
Number of projects presented	632
Number of projects evaluated	629
Number of projects preselected	75
Number of projects selected	22
Success rate	3,50 %

Table: General information of Health Research 2019 Call for Proposals.

Resultados Health Research 2018

Health Research 2018 Call for Proposals - information
HR17 Budget	12.000.000 €
Number of projects presented	785
Number of projects evaluated	785
Number of projects preselected	77
Number of projects selected	20

Table: General information of Health Research 2018 Call for Proposals.

Projetos selecionados Health Research 2022

Code	Project Title	Project Leader	Host Organization	Partner Organizations	Thematic Area	Category	Budget (€)
HR22-00073	R-loop-mediated genome instability factors in cancer	Andrés Aguilera	Universidad de Sevilla	N/A	Oncology	Individual	500,000
HR22-00100	Using small-molecule inhibitors to explore the unique properties of the bacterial K+ machinery and its potential as an antibacterial target	João Morais Cabral	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação	N/A	Infectious disease	Individual	498,999
HR22-00123	Moving from reactive to proactive strategies for the prevention of the next West Nile virus outbreak in Andalucía	Jordi Figuerola	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Infectious disease	Individual	499,909.28
HR22-00172	(Epi)Genomic and microenvironment interactions driving evolution in chronic lymphocytic leukemia. Targets for clinical intervention	Elías Campo	Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	Fundación Universidad de Oviedo; Centre de Regulació Genòmica (CRG)	Oncology	Research Consortium	999,806.30
HR22-00189	Neuromorphic devices for adaptive real-time neuromodulation in brain electrical stimulation therapies	Paulo Aguiar	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação	Universidade do Porto; Consejo Superior de Investigaciones Científicas (CSIC); Centro Hospitalar Universitário do Porto, E.P.E.	Enabling Technologies	Research Consortium	965,888.78
HR22-00221	Antibody-mediated NMDA receptor encephalitis: symptoms, biomarkers, and mechanisms of the prolonged recovery stage	Josep Dalmau	Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	Fundació Privada per a la Recerca i la Docència Sant Joan de Déu	Neuroscience	Research Consortium	972,352.39
HR22-00253	Harnessing the adaptive immune response in vascular pathologies: towards the identification of new therapeutic avenues	Almudena R. Ramiro	Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC	Fundación Instituto de Investigación Sanitaria of the Fundación Jiménez Díaz	Cardiovascular and associated metabolic diseases	Research Consortium	750,042.40
HR22-00316	Understanding and promoting the growth and regenerative functions of blood vessels in heart disease	Rui Benedito	Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC	Centre de Regulació Genòmica (CRG); Fundació Institut de Recerca Contra la Leucèmia Josep Carreras; University Hospital RWTH Aachen	Cardiovascular and associated metabolic diseases	Research Consortium	999,948.04
HR22-00394	Epigenetic basis of gene-environment interactions underlying variation in Cognitive capabilities and their Decline with Age	Angel Barco	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Neuroscience	Individual	498,000
HR22-00395	Vascularized lymphoma on-chip: a multifaceted tool for translational research	Patricia Perez	Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	European Molecular Biology Laboratory Barcelona	Enabling Technologies	Research Consortium	499,871.26
HR22-00402	Potentiating cancer immunotherapy by inhibiting the NMD quality-control pathway guided by genetic markers	Fran Supek	Fundació Institut de Recerca Biomèdica (IRB Barcelona)	Universitat Pompeu Fabra (UPF)	Oncology	Research Consortium	998,900.50
HR22-00405	Accelerated evolution of high-weight protein complexes for precision antimicrobials	Alfonso Jaramillo	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Enabling Technologies	Individual	482,730
HR22-00447	Metabolic communication between immune cells orchestrates the response to pathogens	Nuria Martínez	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Infectious disease	Individual	496,685.86
HR22-00529	Novel mutational mechanisms of somatic retrotransposition in the context of the 3D cancer genome	Jose Tubio	Universidad de Santiago de Compostela	N/A	Oncology	Individual	495,476.89
HR22-00533	A DIRect QuanTitative assessment of Heart disease with magnetic resonance imaging	Teresa Matias	Centro De Ciências Do Mar Do Algarve	Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC; Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento; Universidad de Valladolid	Cardiovascular and associated metabolic diseases	Research Consortium	998,472.90
HR22-00551	Endothelial Cells as rheostats for Age-Related Diseases	Claudio Franco	Instituto de Medicina Molecular	N/A	Cardiovascular and associated metabolic diseases	Individual	499,818.88
HR22-00569	NRF2 as a novel therapeutic target in early and intermediate age-related macular degeneration	Miguel Seabra	Universidade Nova de Lisboa	Centro Investigation Biomedica en Redes Neurodegenerativas - CIBERNED	Neuroscience	Research Consortium	985,013
HR22-00602	New nanotechnological therapy for Parkinson's disease: nose to brain delivery of GBA-polymer nanoconjugates	Marta Martínez	Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)	Universitat Autònoma de Barcelona (UAB); Centro de Investigación Príncipe Felipe	Neuroscience	Research Consortium	599,723.00
HR22-00668	Uncovering the Differentiation Determinants and Dynamics of Congenital Susceptibility to Infections	Esteban Ballestar	Fundació Institut de Recerca Contra la Leucèmia Josep Carreras	Fundació Josep Carreras contra la Leucemia	Infectious disease	Individual	477,722.19
HR22-00681	Epigenetic regulation of host immunity and neurological long-term consequences of SARS-CoV-2 infection	Christian Brander	Institut de Recerca de la Sida "la Caixa" - IRSICAIXA	Centre de Regulació Genòmica (CRG); Fundació FLS de lluita contra la sida, les malalties infeccioses i la promoció de la salut i la ciencia; Institut De Recerca I Tecnología Agroalimentaria	Infectious disease	Research Consortium	999,580
HR22-00702	Multifunctional nano-immunotherapy against breast brain metastases	Helena Florindo	FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento	Tel Aviv University	Enabling Technologies	Research Consortium	853,405.70
HR22-00722	The BioPlaTTAR Platform for the Tailored and Rapid Development of Antiviral Biopharmaceuticals	Cláudio Manuel Soares	Universidade Nova de Lisboa	Instituto de Medicina Molecular; Fundação Calouste Gulbenkian; Consejo Superior de Investigaciones Científicas (CSIC)	Enabling Technologies	Research Consortium	1,000,000
HR22-00732	Somatic mutations and clonal hematopoiesis as predictors and drivers of heart failure progression	José Javier Fuster	Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC	Fundació Institut de Recerca Contra la Leucèmia Josep Carreras; Fundació Institut d’Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP); Fundació Josep Carreras contra la Leucemia; Fundació Institut de Recerca Biomèdica (IRB Barcelona); Fundación para la Formación e Investigación Sanitarias de la Región de Murcia	Cardiovascular and associated metabolic diseases	Research Consortium	998,043.28
HR22-00741	Harnessing germinal centre regulation for improved vaccines	Luis Graca	Instituto de Medicina Molecular	Cultivamos Cultura	Infectious disease	Individual	499,952
HR22-00754	Role of diet-derived retinoids in CD8αα intraepithelial lymphocytes and intestinal defence at early-life	Manuela Ferreira	Universidade de Coimbra	N/A	Infectious disease	Individual	408,077.71
HR22-00776	Role of cellular senescence during breast cancer progression and treatment	Joaquín Arribas	Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)	N/A	Oncology	Individual	500,000
HR22-00778	Circuit mechanisms for associating high-order cortical activity with expected sensory representations in health and desease	Leopoldo Petreanu	Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud	N/A	Neuroscience	Individual	499,976.40
HR22-00799	T cell acute lymphoblastic leukemia: Origin & Relapse	Vera Sofia Correia Martins	Fundação Calouste Gulbenkian	Universität Ulm	Oncology	Research Consortium	681,932.54
HR22-00813	Highly efficient technology for clean and safe air: development of advanced air purifiers to inactivate pathogens in aerosols	Miguel A. Bañares	Consejo Superior de Investigaciones Científicas (CSIC)	Fundación para la Investigación Biomédica del Hospital Universitario La Paz; Hospital Universitario Severo Ochoa	Enabling Technologies	Research Consortium	997,000
HR22-00854	The dynamic membrane traffic at the neuronal synapse: Endosomal sub-compartments in health and disease	Ira Milosevic	Universidade de Coimbra	N/A	Neuroscience	Individual	492,837.85
HR22-00879	Whole-systems Analysis of the Microbiome-Metabolome Crosstalk for Biomarker Discovery and Therapy of Respiratory Fungal Diseases	Cristina Cunha	Universidade do Minho	N/A	Infectious disease	Individual	499,646.79
HR22-00890	Modulating nucleolar activity and stress responses as a therapeutic strategy in ALS	Oscar Fernandez-Capetillo	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	N/A	Neuroscience	Individual	498,850

Projetos selecionados Health Research 2021

Code	Project Title	Project Leader	Host Organization	Partner Organizations	Thematic Area	Category	Budget (€)
HR21-00046	Decoding the paracrine control of metabolic fitness by endothelial nutrient signaling	Alejo Efeyan	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	Cardiovascular and associated metabolic diseases	Research Consortium	992.580,60
HR21-00386	High precision cardioprotective therapy: a photoswitchable approach to reduce the extension of myocardial infarction	Amadeu Llebaria	Consejo Superior de Investigaciones Científicas (CSIC)	Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) - Purdue University, West Lafayette, IN - GICOR	Cardiovascular and associated metabolic diseases	Research Consortium	999.779,50
HR21-00430	Phospholipid biosynthesis and transport between endoplasmic reticulum and mitochondria: understanding their essential role in liver disorders	Antonio Zorzano	Fundació Institut de Recerca Biomèdica (IRB Barcelona)	Universitat de Barcelona - Fundació Institut d'Investigació Sanitària Pere Virgili	Cardiovascular and associated metabolic diseases	Research Consortium	997.014
HR21-00233	Loss of Triadin impairs cardiac proteostasis disclosing pathophysiological complexity in Catecholaminergic Polymorphic Ventricular Tachycardia Type 5	Silvia Giuliana Priori	Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC	N/A	Cardiovascular and associated metabolic diseases	Individual	496.100
HR21-00793	RIPK3 biology and targeting in metabolic liver disease	Cecilia Rodrigues	FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento	N/A	Cardiovascular and associated metabolic diseases	Individual	320.000,07
HR21-00375	Massively parallel mutagenesis to understand, predict and prevent amyloid nucleation in neurodegenerative diseases	Ben Lehner	Centre de Regulació Genòmica (CRG)	Institut de Bioenginyeria de Catalunya	Enabling technologies	Research Consortium	994.048,90
HR21-00925	Development of enabling technologies for T-cell immunotherapy of solid tumors	Sonia Guedán	Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	Asociación Centro de Investigación Cooperativa en Biociencias (CIC bioGUNE) - Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)	Enabling technologies	Research Consortium	963.488
HR21-00410	Graphene aptasensor bioelectronics: a neural interface for neurotransmission probing in neurological disorders	Pedro Alpuim	Laboratorio Iberico Internacional de Nanotecnologia	Universidade do Minho - Consejo Superior de Investigaciones Científicas (CSIC)	Enabling technologies	Research Consortium	997.692,19
HR21-00208	Enzyme propelled nanobots as efficient nanotech platform for bladder cancer therapy	Samuel Sánchez	Institut de Bioenginyeria de Catalunya	Asociación Centro de Investigación Cooperativa en Biomateriales - Universitat Autònoma de Barcelona (UAB) - Fundació Clínic per a la Recerca Biomèdica -Fundacio Catalunya-La Pedrera Fundacio Especial - Universitat de Barcelona - Fundació Bosch i Gimpera	Enabling Technologies	Research Consortium	997.946,50
HR21-00415	A multidisciplinary approach to understand host and pathogen interactions to develop new strategies to target tuberculosis	Margarida Saraiva	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação	Consejo Superior de Investigaciones Científicas (CSIC) - Francis Crick Institute	Infectious diseases	Research Consortium	998.404
HR21-00848	Whole-organism vaccines against P. falciparum and P. vivax malaria with enhanced efficacy and scope	Miguel Prudêncio	Instituto de Medicina Molecular	Leiden University Medical Centre - US Naval Medical Research Unit 6	Infectious diseases	Research Consortium	997.453,50
HR21-01020	Neuron-astrocyte signaling in depression: learning from astrocytes how to effectively treat depression	João Filipe Oliveira	Universidade do Minho	N/A	Neuroscience	Individual	499.478,45
HR21-00171	Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria	Hernando A. del Portillo	Institut de Salut Global de Barcelona (ISGlobal)	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação - Universitat de Barcelona - Mahidol University	Infectious diseases	Research Consortium	996.930,57
HR21-00368	Molecular dissection of TNF-mediated pathogenic macrophage necrosis in tuberculosis	Francisco Jose Roca Soler	Universidad de Murcia	N/A	Infectious diseases	Individual	460.252,80
HR21-00737	Acquisition of antifungal resistance in pathogenic Candida spp.: evolutionary paths, fitness trade-offs, and interplay with the immune system	Toni Gabaldón	Fundació Institut de Recerca Biomèdica (IRB Barcelona)	N/A	Infectious diseases	Individual	499.244
HR21-00622	In vivo reprogramming to rescue alterations in Huntington’s disease	Josep M. Canals	Universitat de Barcelona - Fundació Bosch i Gimpera	Lund University - Cardiff University - Institute of Molecular Biotechnology (IMBA)- European Huntington's Disease Network	Neuroscience	Research Consortium	994.890
HR21-00259	From GFAP mutations in astrocytes to neurodegeneration: exploring a lipid-protein oxidation pathway	Dolores Pérez-Sala	Consejo Superior de Investigaciones Científicas (CSIC)	Brain Center, University Medical Center Utrecht -University of Copenhagen - University of Gothenburg -Institut De Recerca Biomedica De Lleida. Fundació Dr. Pifarre	Neuroscience	Research Consortium	1.000.000
HR21-00824	A strategy to guide and promote spinal and visual axons regeneration after injury	Eloísa Herrera	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Neuroscience	Individual	495.500
HR21-01136	Deep learning of a hippocampal memory code in health and disease	Liset Menéndez de la Prida	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Neuroscience	Individual	491.700
HR21-01208	RBM10, a novel splicing regulator and tumor suppressor: from mechanisms to therapies	Juan Valcárcel	Centre de Regulació Genòmica (CRG)	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	Oncology	Research Consortium	816.239,46
HR21-00176	Understanding lncRNAs in replicative stress and colorectal cancer: from cancer biology to single-molecules	Maite Huarte	Fundación para la Investigación Médica Aplicada (FIMA/CIMA)	Consejo Superior de Investigaciones Científicas (CSIC) - Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	Oncology	Research Consortium	995.200
HR21-00761	IL7R in lung cancer development, metastasis and resistance to immune checkpoint inhibitor therapy	João Barata	Instituto de Medicina Molecular	Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre - Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	Oncology	HR Consortium	999.962
HR21-00083	Interleukin-8 and neutrophil extracelular traps as actionable hurdles for cancer immunotherapy	Ignacio Melero	Fundación para la Investigación Médica Aplicada (FIMA/CIMA)	N/A	Oncology	Individual	498.850
HR21-00020	Cracking the cancer tubulin code for precision oncology	Helder Maiato	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação	N/A	Oncology	Individual	499.983
Projetos premiados em colaboração com a Fundação Luzon
HR21-00931	Targeting TDP-43 with protein kinase inhibitors: a effective and measurable therapy for ALS	Ana Martinez	Consejo Superior de Investigaciones Científicas (CSIC)	FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento -Universidad Complutense de Madrid	Neuroscience	Research Consortium	500.000
Projetos premiados em colaboração com a Fundação para a Ciência e a Tecnologia, I.P. no âmbito da "Iniciativa Ibérica de Investigação e Inovação Biomédica, i4b"
HR21-01212	Decoding the non-code of beta-cells cis-regulation	Jose Bessa	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação	N/A	Cardiovascular and associated metabolic diseases	Individual	499.355
HR21-00605	Protecting the brain from metastatic breast cancer	Miguel Castanho	Instituto de Medicina Molecular	Asociación Instituto Biodonostia - FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento - Asociación Centro de Investigación Cooperativa en Biomateriales	Enabling Technologies	Research Consortium	632.841
HR21-00533	A flexible platform for generating synthetic virus to control infectious diseases	Joana Azeredo	Universidade do Minho	N/A	Infectious diseases	Individual	492.460,48
HR21-01077	Regulation of prefrontal cortical synaptic function and behavior by chronic stress-induced microRNA-186-5p	Paulo Pinheiro	Centro de Neurociências e Biologia Celular	N/A	Neuroscience	Individual	492.304,48
HR21-00077	Regulatory RNA–protein interactions at telomeres in healthy cells and during malignant transformation	Claus Maria Azzalin	Instituto de Medicina Molecular	N/A	Oncology	Individual	495.792

Projetos selecionados Health Research 2020

Code	Project Title	Project Leader	Host Institution	Partner Institutions	Thematic Area	Category	Budget (€)
HR20-00493	Function of a novel program of islet microexons in beta cell development, insulin secretion and diabetes	Manuel Irimia	Centre de Regulació Genòmica (CRG)	N/A	Cardiovascular and metabolic diseases	Individual	499.592
HR20-00075	Flow-driven inflammation and arterial wall remodeling in atherosclerosis: mechanisms and therapeutic potential	Miguel Ángel del Pozo	Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC	Yale University, New Haven, CT, Aarhus University, Asociación Centro de Investigación Cooperativa en Biomateriales	Cardiovascular and metabolic diseases	Research Consortium	999.987
HR20-00322	RNA mis-splicing in hypertrophic cardiomyopathy: opportunities for diagnosis and therapy	Maria Carmo-Fonseca	Instituto de Medicina Molecular	Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento, Associação para Investigação e Desenvolvimento da Faculdade de Medicina	Cardiovascular and metabolic diseases	Research Consortium	986.964
HR20-00051	Succinate/SUCNR1 axis: a novel target for anti-obesity therapies	Sonia Fernandez	Fundació Institut d'Investigació Sanitària Pere Virgili	Universidad de Santiago de Compostela, Institut D'Investigació Biomèdica De Girona (IDIBGI)	Cardiovascular and metabolic diseases	Research Consortium	998.902
HR20-00369	Enabling technologies to map nuclear mechanosensing: from organoids to tumors	Xavier Trepat	Institut de Bioenginyeria de Catalunya	Netherlands Cancer Institute	Enabling technologies	Research Consortium	984.630
HR20-00800	Deep Learning to Dissect the Interaction between Leukemic Cells and the Ageing Niche	M. Carolina Florian	Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)	Universität Ulm	Enabling technologies	Research Consortium	817.045
HR20-00637	BioPrinted hydROgel MicrofluIdicS to mimic patient-specific tumor mEtastatic microenvironment	Elena Martinez	Institut de Bioenginyeria de Catalunya	Laboratorio Ibérico Internacional de Nanotecnologia, Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)	Enabling technologies	Research Consortium	981.675
HR20-00428	Heterogenous protein acylation and cancer	Gemma Triola	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Enabling technologies	Individual	341.242
HR20-00218	Enhancing Tissue-Specific Immune Microenvironments for the Cure of HIV	María José Buzón	Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)	Consejo Superior de Investigaciones Científicas (CSIC), Institut de Recerca de la Sida "la Caixa" - IRSICAIXA	Infectious diseases	Research Consortium	699.134
HR20-00361	Mechanism and function of epitranscriptomic poly(A) tail modifications in African trypanosomes	Luisa Figueiredo	Instituto de Medicina Molecular Joao Lobo Antunes	N/A	Infectious diseases	Individual	499.400
HR20-00635	Coping with unpredictability: regulatory plasticity as an adaptation strategy in the human malaria parasite	Elena Gomez-Díaz	Consejo Superior de Investigaciones Científicas (CSIC)	University of Glasgow, University of Sciences, Techniques and Technologies of Bamako (USTTB), Malaria Rsearch and Training Center	Infectious diseases	Research Consortium	999.548
HR20-00584	Discovery of new antiparasitic drug candidates and innovative modes of actions from Microbial Natural Products	Olga Genilloud	Fund. Centro de Excelencia en Inv. de Medicamentos Innovadores en Andalucia	Drugs for Neglected Diseases Initiative (DNDi), Institut Pasteur korea	Infectious diseases	Research Consortium	995.251
HR20-01000	Encoding reward and aversion in the mammalian brain: the overlooked role of endogenous opioids	Ana Joao Rodrigues	Universidade do Minho	N/A	Neuroscience	Individual	499.788
HR20-00083	Restoration of sensory circuits based on glia-to-neuron reprogramming	Guillermina López-Bendito	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Neuroscience	Individual	499.000
HR20-00081	Amino acid transporter structure to target glutamate transmission in neuro diseases	Manuel Palacin	Fundació Institut de Recerca Biomèdica (IRB Barcelona)	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	Neuroscience	Research Consortium	428.500
HR20-00896	Mitochondrial transcription as a trigger for neurodegenation	Albert Quintana	Universitat Autònoma de Barcelona (UAB)	N/A	Neuroscience	Individual	500.000
HR20-00714	A cortical pathogenesis of Parkinson's disease	Guglielmo Foffani	Fundación de Investigación HM Hospitales	N/A	Neuroscience	Individual	500.000
HR20-00465	Immunomodulatory drivers in melanoma progression and therapy response	Marisol Soengas	Fund. del Sector Público Estatal Centro Nacional de Inv. Oncológicas Carlos III	N/A	Oncology	Individual	481.597
HR20-00164	A new functional paradigm for RhoA gene mutations in peripherial Tcell Lymphoma: Functional and Clinical implications	Xose R. Bustelo	Fundación de Investigación del Cancer	N/A	Oncology	Individual	498.300
HR20-00871	Gene Regulatory NETworks in NORmal and MALignant Hematopoiesis-Identification and Targeting (GR-NET NORMAL-HIT)	Felipe Prosper	Universidad de Navarra	Fundación para la Investigación Médica Aplicada (FIMA/CIMA), Fundación Miguel Servet - Navarrabiomed, University of Cambridge	Oncology	Research Consortium	999.410
HR20-00411	Virtual patient derived xenografts for tumor treatment	Luciano Di Croce	Centre de Regulació Genòmica (CRG)	Fundació Sant Joan de Déu	Oncology	Research Consortium	990.160
Proyectos galardonados en colaboración con la Fundación Luzón
HR20-01109	Brain Liquid Biopsy for Alzheimer disease and neurodegenerative disorders	Maite Mendioroz	Fundación Miguel Servet - Navarrabiomed	N/A	Neuroscience	Individual	482.847
Proyectos galardonados en colaboración con la Fundação para a Ciência e a Tecnologia, I.P. en el marco de la “Iniciativa Ibérica de Investigaçao e Inovaçao Biomédica, i4b"
HR20-00249	Diamond Photonics Platforms for Synaptic Connectivity Assessment in Healthy and Parkinson Disease Neuronal Models	Jana B. Nieder	Laboratorio Ibérico Internacional de Nanotecnologia	Universidade do Minho, Universidade de Aveiro	Enabling technologies	Research Consortium	999.981
HR20-00841	Unravelling pulmonary neuroimmune circuits during infection	Henrique Veiga-Fernandes	Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud	N/A	Infectious disease	Individual	499.950
HR20-00904	Potassium channel dysfunction in models of neurodevelopmental disorders	Ana Luisa Carvalho	Centro de Neurociências e Biologia Celular	IINS - Interdisciplinary Institute for Neuroscience, CNRS 5297, University of Bordeaux	Neuroscience	Research Consortium	782.000

Projetos selecionados Health Research 2019

Code	Project Title	Project Leader	Host Institution	Partner Institutions	Thematic Area	Category	Budget (€)
HR1818-00120	Mapping the pathogenesis of vascular malformations	Mariona Graupera	Institut d'Investigació Biomèdica de Bellvitge	Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.), Fundación Privada Hospital de la Santa Creu i Sant Pau, Fundació Sant Joan de Déu	Cardiovascular and metabolic diseases	Research Consortium	755.018
HR1818-00068	Nitric Oxide signaling and proteoglycans in Marfan syndrome’s aortopathy: mechanisms and new therapeutic targets	Juan Miguel Redondo Moya	Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)	Consejo Superior de Investigaciones Científicas	Cardiovascular and metabolic diseases	Research Consortium	500.000
HR1818-00304	Dysfunction of Ion Channel Complexes in Inheritable Cardiac Diseases	José Jalife	Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)	N/A	Cardiovascular and metabolic diseases	Individual	499.895
HR1818-00100	Hypothalamic control of gut function and microbiota composition: implications for energy balance regulation	Marc Claret Carles	Institut d'Investigacions Biomèdiques August Pi i Sunyer	Université catholique de Louvain (UCLouvain), Universidad de Santiago de Compostela	Cardiovascular and metabolic diseases	Research Consortium	972.183
HR1818-00359	Origin and functions of the tumor stroma in metastatic colorectal cancer	Eduard Batlle	Fundació Institut de Recerca Biomèdica (IRB Barcelona)	N/A	Oncology	Individual	499.997
HR1818-00069	Next-generation CAR-DOT cells for allogeneic adoptive cancer immunotherapy	Bruno Miguel de Carvalho Silva-Santos	Instituto de Medicina Molecular	Josep Carreras Leukemia Research Institute (JCLRI)	Oncology	Research Consortium	999.997
HR1818-00302	Post-transcriptional gene regulation reprogramming in obesity-driven liver cancer	Raúl Méndez	Fundació Institut de Recerca Biomèdica (IRB Barcelona)	N/A	Oncology	Individual	499.883
HR1818-00256	Defining The Role of Exosome-Secreted Micropeptides in Pancreatic Cancer	Maria Abad	Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)	Fundación Centro Nacional de Investigaciones Oncológicas Carlos III, Champalimaud Foundation	Oncology	Research Consortium	694.600
HR1818-00023	Targeting Telomeres in Cancer	Maria A. Blasco	Fundación Centro Nacional de Investigaciones Oncológicas Carlos III	N/A	Oncology	Individual	489.100
HR1818-00589	Sensitizing pancreatic cancer to immunotherapy with multimodal precision nanomedicines	Maria Jesús Vicent Docón	Centro de Investigación Príncipe Felipe	Facultade de Farmacia da Universidade de Lisboa, Sackler Faculty of Medicine. Tel Aviv University	Enabling technologies	Research Consortium	985.042
HR1818-00501	Light-regulated drugs to restore sight	Pau Gorostiza Langa	Institut de Bioenginyeria de Catalunya	Universidad Miguel Hernández de Elche (UMH), Consejo Superior de Investigaciones Científicas, Barcelona Macula Foundation Research (BMF), Universidad de Alcalá (UAH)	Enabling technologies	Research Consortium	498.051
HR1818-00336	Community-Driven Big Data Intelligence to Fight Mosquito-Borne Disease	Frederic Bartumeus Ferré	Consejo Superior de Investigaciones Científicas	Universitat Pompeu Fabra, Max Planck Institute for Demographic Research (MPDIR), National Center of Epidemiology (CNE). CIBERESP/ISCIII., Centre for Ecological Research and Forestry Applications (CREAF), Agència de Salut Pública de Barcelona (ASPB),Agencia de Salut Pública de Catalunya (ASPCAT). Generalitat de Catalunya, Centro de Coordinación de Alertas y Emergencias Sanitarias (CCAES)	Enabling technologies	Research Consortium	999.920
HR1818-00313	Adaptive Retinal Implant Technology for Vision Restoration	Jose Antonio Garrido Ariza	Fundació Institut Català de Nanociència i Nanotecnologia	Institut de Física d'Altes Energies (IFAE), The Institute of Photonic Sciences (ICFO), Barraquer Foundation (BF), Institut de la Vision (Sorbonne Université)	Enabling technologies	Research Consortium	999.715
HR1818-00058	Bacterial lung chassis for treating human lung infectious diseases	Luis Serrano Pubul	Fundació Centre de Regulació Genòmica	Institut d'Investigacions Biomèdiques August Pi i Sunyer	Infectious diseases	Research Consortium	999.528
HR1818-00469	Locking cells against Ebola virus	Carmen Gil	Consejo Superior de Investigaciones Científicas	Instituto de Investigación Biomédica Hospital 12 de Octubre (Imas12), Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Bernhard Nocht Institute for Tropical Medicine	Infectious disease	Research Consortium	995.068
HR1818-00267	Dissecting the initial molecular events that trigger sexual conversion and transmission in malaria parasites	Alfred Cortés Closas	Barcelona Institute for Global Health (ISGlobal)	N/A	Infectious diseases	Individual	499.400
HR1818-00104	Enhancing Tissue Resident Immunity	Marc Veldhoen	Instituto de Medicina Molecular	N/A	Infectious diseases	Individual	497.158
HR1818-00155	Exosome targeting of the hypothalamus: a novel strategy for the treatment of obesity	Miguel Antonio López Pérez	Universidad de Santiago de Compostela	N/A	Neuroscience	Individual	448.300
HR1818-00026	DUbbing Language-therapy CINEma-based in Aphasia post-Stroke. A feasibility cross-over pilot-trial	Blanca Fuentes Gimeno	Hospital Universitario la Paz	Universidad Pontificia de Comillas, Afasia Activa	Neuroscience	Research Consortium	308.066
HR1818-00178	Dyslexia and the thalamus: Integrating anatomy and function in a mechanistic account of the reading brain	Manuel Francisco Carreiras Valiña	Asociacion Basque Center on Cognition, Brain and Language	N/A	Neuroscience	Individual	500.000
HR1818-00452	Modulation of Tau seeding and pathology in tauopathies by BBB-nanocarriers, epitope selective vaccination and ectoPrP Tau receptor bodies	José Antonio Del Río Fernández	Institut de Bioenginyeria de Catalunya	Institut d'Investigació Biomèdica de Bellvitge, Institute for Research in Biomedicine (IRB Barcelona), Universitat de Barcelona and Institute of Complex Systems (UBICS)	Neuroscience	Research Consortium	763.002
HR1818-00007	Dynamics of the neural, metabolomic and neuropsychological signatures underlying the adaptations for motherhood during pregnancy	Oscar Vilarroya Oliver	Universitat Autònoma de Barcelona	Fundació Institut Mar d'Investigacions Mèdiques, Instituto de Investigación Sanitaria Gregorio Marañón , University of Lleida-IRBLleida, Reproductive Medicine Service at Dexeus Women Health	Neuroscience	Research Consortium	972.414
Projetos premiados em colaboração com a Fundação Luzon
HR1818-000341	A potential metabolic-targeted therapeutic for Amyotrophic lateral sclerosis (ALS): Leptin	Carmen Maria Fernandez-Martos	Fundación Hospital Nacional de Parapléjicos	San Pablo University, King´s College London and Wicking Dementia Centre/University of Tasmania	Neuroscience	Research Consortium	499979
Projetos premiados em colaboração com a Fundação para a Ciência e a Tecnologia, I.P. no âmbito da "Iniciativa Ibérica de Investigação e Inovação Biomédica, i4b"
HR1818-00187	Targeting induced-senescent cells: a novel approach to promote spinal cord regeneration in mammals	Leonor Saúde	Instituto de Medicina Molecular	N/A	Neuroscience	Individual	444048
HR1818-00502	Metabolic Reprograming In Sepsis	Miguel Che Parreira Soares	Fundação Calouste Gulbenkian	Universitätsklinikum Jena, Center for Sepsis Control and Care, Thüringen (Germany)	Infectious disease	Research Consortium	500000

Projetos selecionados Health Research 2018

Code	Project Title	Project Leader	Host Institution	Partner Institutions	Thematic Area	Category	Budget (€)
HR17- 00016	Readying immune cells prior to disease-inducing encounters	Francisco Sánchez-Madrid	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	N/A	Infectious disease	A	499.731
HR17- 00040	Understanding muscle regenerative decline with aging	Pura Muñoz-Cánoves	Universitat Pompeu Fabra (UPF)	N/A	Other biomedical areas	A	496.630
HR17- 00092	Metastasis Cell Fate Mapping	Roger Gomis Cabré	Institute for Research in Biomedicine (IRB)	N/A	Oncology	A	489.400
HR17- 00094	Eradicating prostate cancer metastasis before clinical manifestation	Arkaitz Carracedo	CIC bioGUNE	University of Cambridge (UK), Fundação Champalimaud (Lisboa), CIC biomaGUNE, Basurto Hospital	Oncology	A	499.915
HR17- 00149	A Translational Model of Antibody-mediated Synaptic Disease: Symptoms, Neuronal Circuits, and the Mechanisms of Memory Loss and Recovery	Josep Dalmau Obrador	Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	N/A	Neuroscience	A	498.718
HR17- 00199	Towards a universal therapeutic vaccine against chronic virus infections	Andreas Meyerhans	Universitat Pompeu Fabra (UPF)	IrsiCaixa	Infectious disease	A	484.316
HR17- 00221	Genomic and epigenomic drivers of disease evolution in chronic lymphocytic leukemia. Targets for clinical intervention	Elías Campo	Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	Universidad de Oviedo (UNIOVI), Barcelona Supercomputing Center (BSC)	Oncology	B	999.270
HR17- 00231	Regenerating photoreceptors in human retinal organoids to establish a treatment for Retinitis Pigmentosa	Maria Pia Cosma	Fundació Centre de Regulació Genòmica (CRG)	Institute for Bioengineering of Catalonia (IBEC), Instituto Barraquer	Neuroscience	A	499.519
HR17- 00232	Exploiting post-transcriptional regulation to uncover novel vulnerabilities of metastatic cells	Fátima Gebauer Hernández	Fundació Centre de Regulació Genòmica (CRG)	Centro Nacional de Investigaciones Oncológicas (CNIO)	Oncology	A	499.980
HR17- 00247	The antibody immune response during vascular remodeling	Almudena Rodríguez Ramiro	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Fundación Jimenez Diaz	Cardiovascular disease	A	499.963
HR17- 00264	Plasmodium Exploitation of Liver-specific Methionine Metabolism	Maria M. Mota	Instituto de Medicina Molecular (IMM), Lisboa	N/A	Infectious disease	A	499.950
HR17- 00267	Somatic Mutation-driven Clonal Hematopoiesis in Atherosclerosis - International Consortium	Valentí Fuster	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	University of Virginia (UVA)	Cardiovascular disease	B	999.896
HR17- 00268	Therapeutic targeting of MBNL microRNAs as innovative treatments for myotonic dystrophy	Ruben Artero-Allepuz	Universitat de Valencia	University of Oxford (UK), Institute for Bioengineering of Catalonia (IBEC), Institut IMAGINE (France), Institute Biodonostia, ASEM & Myotonic Dystrophy Foundation	Other biomedical areas	B	997.024
HR17- 00323	Optical dissection of cortical circuits for sensory expectations	Leopoldo Petreanu	Fundação Champalimaud, Lisboa	N/A	Neuroscience	A	499.708
HR17- 00409	Fighting Zika virus with antiviral peptides and conjugates translocating blood-placental and blood-brain barriers	David Andreu Martínez	Universitat Pompeu Fabra (UPF)	Instituto de Medicina Molecular (IMM), Instituto de Bioquímica Médica Leopoldo de Meis	Infectious disease	B	777.250
HR17- 00513	Modulation of age-dependent neuromelanin accumulation as a novel therapeutic strategy for Parkinson’s disease and brain aging	Miquel Vila Bover	Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)	N/A	Neuroscience	A	466.004
HR17- 00527	Therapeutic targeting of the neutrophil clock in cardiovascular disease	Andrés Hidalgo Alonso	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Universidad Complutense de Madrid (UCM), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	Cardiovascular disease	A	499.998
HR17- 00539	Identifying and testing the metabolites generated by two psychoactive gut bacteria to alter brain function and behavior	Carlos Vidal Ribeiro	Fundação Champalimaud, Lisboa	N/A	Neuroscience	A	463.694
HR17- 00595	Organismal role of the ER membrane complex: a conserved machinery required for membrane protein biogenesis.	Colin Adrain	Calouste Gulbenkian Foundation, Lisboa	Institute of Chemical and Biological Technology (ITQB-NOVA, Lisboa), Institute of Organic Chemistry and Biochemistry of the CAS (Czech Republic)	Other biomedical areas	B	960.769
HR17- 00627	Dissecting the functional role of the epicardium metabolism during heart development and repair after myocardial infarction	Ofelia María Martínez Estrada	Fundació Bosch i Gimpera (UB)	Fundació Hospital Universitari Vall d'Hebron Institut de Recerca (VHIR), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP)	Cardiovascular disease	A	438.100
Projetos premiados em colaboração com a Fundação Luzon
HR17- 00777	Activation of the resolution programs of inflammation as a novel therapeutic approach for the treatment of amyotrophic lateral sclerosis	Rubèn López Vales	Universitat Autònoma de Barcelona (UAB)	N/A	Neuroscience	A	500.000
Projetos premiados em colaboração com a Fundação para a Ciência e a Tecnologia, I.P. no âmbito da "Iniciativa Ibérica de Investigação e Inovação Biomédica, i4b"
HR17- 00523	Adenosine A2A receptors as a new opportunity to manage and detail the neurobiology of emotional distress	Rodrigo A. Cunha	Centro de Neurociências e Biologia Celular (CNC), Coimbra	N/A	Neuroscience	A	333.516
HR17- 00634	A Transdisciplinary Approach to the Identification of Personalized Biomarkers and Therapeutic Targets for Chronic Pulmonary Aspergillosis	Agostinho Albérico Rodrigues de Carvalho	Universidade do Minho	Fundación Universitaria San Pablo (CEU), Foundation for Research and Technology-Hellas, Jena University Hospital and Radboudumc	Infectious disease	B	999.027
HR17- 00601	Exosomal fat-liver axis in nonalcoholic fatty liver disease: function and targeting	Rui Eduardo Mota Castro	Universidade de Lisboa	Instituto Biodonostia, École polytechnique fédérale de Lausanne (EPFL) and CIC bioGUNE	Other biomedical areas	A	500.000
HR17- 00636	Sequential Cardiac Resynchronization Therapy	Joaquim Adelino Correia Ferreira Leite Moreira	Universidade do Porto	N/A	Cardiovascular disease	A	369.248